1256-7 | N Ab [Presence] in Serum or Plasma from Blood product unit | N Ab |
1257-5 | N Ab [Presence] in Serum or Plasma from donor | N Ab |
1258-3 | N Ab [Presence] in Serum or Plasma | N Ab |
1259-1 | N Ag [Presence] on Red Blood Cells from Blood product unit | N Ag |
1260-9 | N Ag [Presence] on Red Blood Cells from donor | N Ag |
1261-7 | N Ag [Presence] on Red Blood Cells | N Ag |
1262-5 | N NOS Ab [Presence] in Serum or Plasma from Blood product unit | N NOS Ab |
1263-3 | N NOS Ab [Presence] in Serum or Plasma from donor | N NOS Ab |
1264-1 | N NOS Ab [Presence] in Serum or Plasma | N NOS Ab |
1265-8 | N NOS Ag [Presence] on Red Blood Cells from Blood product unit | N NOS Ag |
1266-6 | N NOS Ag [Presence] on Red Blood Cells from donor | N NOS Ag |
1267-4 | N NOS Ag [Presence] on Red Blood Cells | N NOS Ag |
2643-5 | N-acetyl-beta-glucosaminidase [Enzymatic activity/volume] in Serum | N-acetyl-beta-glucosaminidase |
33354-2 | N-acetyl-beta-glucosaminidase [Enzymatic activity/volume] in Urine | N-acetyl-beta-glucosaminidase |
48995-5 | N-acetyl-beta-glucosaminidase/Creatinine [Ratio] in Urine | N-acetyl-beta-glucosaminidase/Creatinine |
33299-9 | N-acetyl-L-aspartate [Presence] in Urine | N-acetyl-L-aspartate |
34149-5 | N-acetyl-L-aspartate [Molecules/volume] in Amniotic Fluid | N-acetyl-L-aspartate |
13779-4 | N-acetyl-L-aspartate/Creatinine [Mass ratio] in Urine | N-acetyl-L-aspartate/Creatinine |
29631-9 | N-acetylaspartate [Presence] in Urine | N-acetylaspartate |
33212-2 | N-acetylaspartate [Mass/volume] in Body fluid | N-acetylaspartate |
34610-6 | N-acetylaspartate/Creatinine [Mass ratio] in Urine | N-acetylaspartate/Creatinine |
47710-9 | N-acetylaspartate/Creatinine [Molecular ratio] in Urine | N-acetylaspartate/Creatinine |
21413-0 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in Urine | N-Acetylgalactosamine-4-Sulfatase |
24093-7 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/mass] in Fibroblast | N-Acetylgalactosamine-4-Sulfatase |
24094-5 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/mass] in Leukocytes | N-Acetylgalactosamine-4-Sulfatase |
2645-0 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in Amniotic Fluid | N-Acetylgalactosamine-4-Sulfatase |
2646-8 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in Serum | N-Acetylgalactosamine-4-Sulfatase |
2647-6 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/mass] in Tissue | N-Acetylgalactosamine-4-Sulfatase |
2648-4 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in Leukocytes | N-Acetylgalactosamine-4-Sulfatase |
24095-2 | N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/mass] in Fibroblast | N-Acetylgalactosamine-6-Sulfatase |
24096-0 | N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/mass] in Leukocytes | N-Acetylgalactosamine-6-Sulfatase |
2649-2 | N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/mass] in Tissue | N-Acetylgalactosamine-6-Sulfatase |
24097-8 | N-Acetylglucosamine-6-Sulfatase [Enzymatic activity/mass] in Fibroblast | N-Acetylglucosamine-6-Sulfatase |
24098-6 | N-Acetylglucosamine-6-Sulfatase [Enzymatic activity/mass] in Leukocytes | N-Acetylglucosamine-6-Sulfatase |
2650-0 | N-Acetylglucosamine-6-Sulfatase [Enzymatic activity/volume] in Serum | N-Acetylglucosamine-6-Sulfatase |
34164-4 | N-Acetylglucosamine-6-Sulfatase [Enzymatic activity/mass] in Tissue | N-Acetylglucosamine-6-Sulfatase |
14846-0 | N-acetylprocainamide [Molecules/volume] in Serum or Plasma | N-acetylprocainamide |
17317-9 | N-acetylprocainamide [Mass/volume] in Urine | N-acetylprocainamide |
17806-1 | N-acetylprocainamide [Mass/volume] in Body fluid | N-acetylprocainamide |
3834-9 | N-acetylprocainamide [Mass/volume] in Serum or Plasma | N-acetylprocainamide |
4339-8 | N-acetylprocainamide [Mass] of Dose | N-acetylprocainamide |
29369-6 | N-acetylprocainamide/Procainamide [Mass ratio] in Serum or Plasma | N-acetylprocainamide/Procainamide |
29632-7 | N-acetyltyrosine [Presence] in Urine | N-acetyltyrosine |
13780-2 | N-acetyltyrosine/Creatinine [Mass ratio] in Urine | N-acetyltyrosine/Creatinine |
25119-9 | N-acetyltyrosine/Creatinine [Molecular ratio] in Urine | N-acetyltyrosine/Creatinine |
12603-7 | N-desalkylflurazepam [Presence] in Stool | N-desalkylflurazepam |
13568-1 | N-desalkylflurazepam [Presence] in Serum or Plasma | N-desalkylflurazepam |
14690-2 | N-desalkylflurazepam [Molecules/volume] in Serum or Plasma | N-desalkylflurazepam |
16230-5 | N-desalkylflurazepam [Mass/volume] in Urine by Confirm method | N-desalkylflurazepam |
19614-7 | N-desalkylflurazepam [Presence] in Urine by Screen method | N-desalkylflurazepam |
19615-4 | N-desalkylflurazepam [Presence] in Urine by Confirm method | N-desalkylflurazepam |
19617-0 | N-desalkylflurazepam [Mass/volume] in Urine | N-desalkylflurazepam |
26841-7 | N-desalkylflurazepam [Mass/mass] in Hair | N-desalkylflurazepam |
26866-4 | N-desalkylflurazepam [Mass/mass] in Meconium | N-desalkylflurazepam |
27194-0 | N-desalkylflurazepam [Mass/volume] in Vitreous fluid | N-desalkylflurazepam |
27436-5 | N-desalkylflurazepam [Mass/mass] in Stool | N-desalkylflurazepam |
35605-5 | N-desalkylflurazepam [Mass/volume] in Serum or Plasma by Screen method | N-desalkylflurazepam |
46980-9 | N-desalkylflurazepam [Mass/volume] in Serum or Plasma by Confirm method | N-desalkylflurazepam |
47404-9 | N-desalkylflurazepam [Mass/volume] in Blood by Confirm method | N-desalkylflurazepam |
9652-9 | N-desalkylflurazepam [Mass/volume] in Serum or Plasma | N-desalkylflurazepam |
19618-8 | N-desalkylflurazepam cutoff [Mass/volume] in Urine for Screen method | N-desalkylflurazepam cutoff |
19619-6 | N-desalkylflurazepam cutoff [Mass/volume] in Urine for Confirm method | N-desalkylflurazepam cutoff |
3620-2 | N-ethylnicotinamide [Mass/volume] in Urine | N-ethylnicotinamide |
3835-6 | None | N-ethylnicotinamide |
4248-1 | N-ethylnicotinamide [Mass] of Dose | N-ethylnicotinamide |
4340-6 | None | N-ethylnicotinamide |
35580-0 | N-methyl valine [Mass/volume] in Blood | N-methyl valine |
12542-7 | N-methylacetamide [Mass/volume] in Urine | N-methylacetamide |
27163-5 | N-methylacetamide/Creatinine [Mass ratio] in Urine | N-methylacetamide/Creatinine |
12714-2 | N-methylhistamine [Mass/volume] in Urine | N-methylhistamine |
26053-9 | N-methylhistamine [Molecules/time] in 24 hour Urine | N-methylhistamine |
34344-2 | N-methylhistamine [Molecules/volume] in 24 hour Urine | N-methylhistamine |
34345-9 | N-methylhistamine [Molecules/volume] in Urine | N-methylhistamine |
13781-0 | N-methylhistamine/Creatinine [Mass ratio] in Urine | N-methylhistamine/Creatinine |
34346-7 | N-methylhistamine/Creatinine [Molecular ratio] in Urine | N-methylhistamine/Creatinine |
44340-8 | N-methylhistamine/Creatinine [Mass ratio] in 24 hour Urine | N-methylhistamine/Creatinine |
14167-1 | N-methylimidazoleacetate [Mass/time] in 24 hour Urine | N-methylimidazoleacetate |
38712-6 | N-nitrosodimethylamine [Mass/volume] in Air | N-nitrosodimethylamine |
38713-4 | N-nitrosomorpholine [Mass/volume] in Air | N-nitrosomorpholine |
38367-9 | N-octanoylglycine/Creatinine [Mass ratio] in Urine | N-octanoylglycine/Creatinine |
42028-1 | None | NAACCR ambiguous terminology as basis for diagnosis |
42023-2 | None | NAACCR facility identification system coding system |
42024-0 | None | NAACCR hispanic identification algorithm hispanic origin |
42022-4 | None | NAACCR hospital tumor registration.permanent |
42025-7 | None | NAACCR Indian Health Service linkage |
35350-8 | None | NAACCR survival to last contact (in months) |
12405-7 | Nabumetone [Mass/volume] in Serum or Plasma | Nabumetone |
35497-7 | NADH cytochrome C reductase [Enzymatic activity/mass] in Tissue | NADH cytochrome C reductase |
2651-8 | NADH dehydrogenase [Enzymatic activity/volume] in Plasma | NADH dehydrogenase |
2652-6 | NADH dehydrogenase [Enzymatic activity/volume] in Red Blood Cells | NADH dehydrogenase |
35496-9 | NADH dehydrogenase [Enzymatic activity/mass] in Tissue | NADH dehydrogenase |
2653-4 | NADH methemoglobin reductase [Mass/volume] in Red Blood Cells | NADH methemoglobin reductase |
32703-1 | NADH methemoglobin reductase [Enzymatic activity/mass] in Red Blood Cells | NADH methemoglobin reductase |
51603-9 | NADH methemoglobin reductase [Presence] in Red Blood Cells | NADH methemoglobin reductase |
12406-5 | Nadolol [Mass/volume] in Serum or Plasma | Nadolol |
3836-4 | Nadolol [Presence] in Urine | Nadolol |
3837-2 | Nadolol [Mass/volume] in Urine | Nadolol |
3838-0 | Nadolol [Mass/time] in 24 hour Urine | Nadolol |
4341-4 | Nadolol [Mass] of Dose | Nadolol |
6624-1 | Naegleria fowleri Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | Naegleria fowleri Ab |
6625-8 | Naegleria fowleri Ab [Presence] in Cerebral spinal fluid by Immunoassay | Naegleria fowleri Ab |
7971-5 | Naegleria fowleri Ab [Presence] in Cerebral spinal fluid | Naegleria fowleri Ab |
41444-1 | Naegleria fowleri DNA [Presence] in Cerebral spinal fluid by Probe & target amplification method | Naegleria fowleri DNA |
10694-8 | Naegleria sp identified in Tissue by Organism specific culture | Naegleria sp identified |
10695-5 | Naegleria sp identified in Tissue by Wet preparation | Naegleria sp identified |
10993-4 | Nafcillin [Mass/volume] in Serum or Plasma | Nafcillin |
18951-4 | Nafcillin [Susceptibility] | Nafcillin |
25232-0 | Nafcillin [Mass/volume] in Unspecified specimen | Nafcillin |
346-7 | Nafcillin [Susceptibility] by Minimum lethal concentration (MLC) | Nafcillin |
347-5 | Nafcillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Nafcillin |
348-3 | Nafcillin [Susceptibility] by Disk diffusion (KB) | Nafcillin |
349-1 | Nafcillin [Susceptibility] by Serum bactericidal titer | Nafcillin |
41704-8 | Nafcillin [Susceptibility] by Gradient strip (E-test) | Nafcillin |
53877-7 | NAGS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | NAGS gene mutation analysis |
39113-6 | None | Nail angle |
45804-2 | None | Nails &or calluses trimmed during last 90 days |
23312-2 | None | Nairobi sheep disease virus Ab |
23313-0 | Nairobi sheep disease virus Ab [Titer] in Serum | Nairobi sheep disease virus Ab |
23314-8 | Nairobi sheep disease virus Ab [Presence] in Serum by Immune diffusion (ID) | Nairobi sheep disease virus Ab |
23315-5 | Nairobi sheep disease virus Ab [Presence] in Serum by Immunofluorescence | Nairobi sheep disease virus Ab |
23316-3 | Nairobi sheep disease virus Ab [Presence] in Serum | Nairobi sheep disease virus Ab |
23317-1 | None | Nairobi sheep disease virus Ab |
31524-2 | Nairobi sheep disease virus Ab [Units/volume] in Serum | Nairobi sheep disease virus Ab |
23318-9 | Nairobi sheep disease virus Ag [Presence] in Unspecified specimen by Complement fixation | Nairobi sheep disease virus Ag |
23319-7 | Nairobi sheep disease virus Ag [Presence] in Unspecified specimen by Immunofluorescence | Nairobi sheep disease virus Ag |
23320-5 | Nairobi sheep disease virus Ag [Presence] in Unspecified specimen by Immunoassay | Nairobi sheep disease virus Ag |
31904-6 | Nairobi sheep disease virus Ag [Presence] in Unspecified specimen | Nairobi sheep disease virus Ag |
16218-0 | Nalbuphine [Presence] in Urine by Confirm method | Nalbuphine |
17318-7 | Nalbuphine [Mass/volume] in Serum or Plasma | Nalbuphine |
19605-5 | Nalbuphine [Presence] in Urine by Screen method | Nalbuphine |
20551-8 | Nalbuphine [Mass/volume] in Urine by Confirm method | Nalbuphine |
3839-8 | Nalbuphine [Presence] in Urine | Nalbuphine |
3840-6 | Nalbuphine [Mass/volume] in Urine | Nalbuphine |
3841-4 | Nalbuphine [Mass/time] in 24 hour Urine | Nalbuphine |
4342-2 | Nalbuphine [Mass] of Dose | Nalbuphine |
9777-4 | Nalbuphine [Mass/volume] in Unspecified specimen | Nalbuphine |
19607-1 | Nalbuphine cutoff [Mass/volume] in Urine for Screen method | Nalbuphine cutoff |
19608-9 | Nalbuphine cutoff [Mass/volume] in Urine for Confirm method | Nalbuphine cutoff |
17319-5 | Nalidixate [Mass/volume] in Serum or Plasma | Nalidixate |
18952-2 | Nalidixate [Susceptibility] | Nalidixate |
25261-9 | Nalidixate [Mass/volume] in Unspecified specimen | Nalidixate |
350-9 | Nalidixate [Susceptibility] by Minimum lethal concentration (MLC) | Nalidixate |
351-7 | Nalidixate [Susceptibility] by Minimum inhibitory concentration (MIC) | Nalidixate |
352-5 | Nalidixate [Susceptibility] by Disk diffusion (KB) | Nalidixate |
353-3 | Nalidixate [Susceptibility] by Serum bactericidal titer | Nalidixate |
7034-2 | Nalidixate [Susceptibility] by Gradient strip (E-test) | Nalidixate |
3842-2 | Nalorphine [Mass/volume] in Urine | Nalorphine |
4343-0 | Nalorphine [Mass] of Dose | Nalorphine |
28061-0 | Naloxone [Mass/volume] in Serum or Plasma | Naloxone |
42618-9 | Naloxone [Presence] in Urine by Screen method | Naloxone |
10994-2 | Naltrexone [Mass/volume] in Serum or Plasma | Naltrexone |
12309-1 | Naltrexone [Presence] in Urine | Naltrexone |
18334-3 | Naltrexone [Presence] in Urine by Confirm method | Naltrexone |
19609-7 | Naltrexone [Presence] in Urine by Screen method | Naltrexone |
19610-5 | Naltrexone [Mass/volume] in Urine by Confirm method | Naltrexone |
19611-3 | Naltrexone [Mass/volume] in Urine | Naltrexone |
19612-1 | Naltrexone cutoff [Mass/volume] in Urine for Screen method | Naltrexone cutoff |
19613-9 | Naltrexone cutoff [Mass/volume] in Urine for Confirm method | Naltrexone cutoff |
19132-0 | None | Name |
41972-1 | None | Name |
45965-1 | None | Name |
52418-1 | None | Name |
52421-5 | None | Name |
52425-6 | None | Name |
52458-7 | None | Name |
54125-0 | None | Name |
54138-3 | None | Name |
18606-4 | Current medication name and identifier (DEEDS 5.09) | Name + ID |
18611-4 | Medication administered, name + identifier | Name + ID |
18618-9 | Medication discharge, name + identifier | Name + ID |
42127-1 | None | Name of follow-up contact |
45395-1 | None | Name suffix |
3843-0 | Nandrolone [Presence] in Urine | Nandrolone |
3844-8 | Nandrolone [Mass/volume] in Urine | Nandrolone |
3845-5 | Nandrolone [Mass/time] in 24 hour Urine | Nandrolone |
4344-8 | Nandrolone [Mass] of Dose | Nandrolone |
12435-4 | Naphthalene [Mass/volume] in Serum or Plasma | Naphthalene |
38612-8 | Naphthalene [Mass/volume] in Air | Naphthalene |
12436-2 | Naphthol [Mass/volume] in Serum or Plasma | Naphthol |
33300-5 | Naproxen [Presence] in Urine by Screen method | Naproxen |
3846-3 | Naproxen [Mass/volume] in Serum or Plasma | Naproxen |
4345-5 | Naproxen [Mass] of Dose | Naproxen |
50885-3 | Naproxen [Molecules/volume] in Serum or Plasma | Naproxen |
45429-8 | None | Naps regularly during day |
50027-2 | Narcissus IgE Ab [Units/volume] in Serum | Narcissus sp Ab.IgE |
38553-4 | Narcolepsy associated Ag [Presence] in Serum or Plasma | Narcolepsy associated Ag |
12554-2 | Narcotics and opioids [Identifier] in Urine | Narcotics |
29376-1 | Narcotics and opioids [Identifier] in Blood | Narcotics |
29377-9 | Narcotics and opioids [Identifier] in Gastric fluid | Narcotics |
31088-8 | Narcotics and opioids [Identifier] in Bile fluid | Narcotics |
50398-7 | Narrative diagnostic report [interpretation] in Blood or Tissue by Molecular genetics method Narrative | Narrative diagnostic report |
19979-4 | None | Nasal cannula types |
9036-5 | None | Nasogastric tube site |
49598-6 | Natalizumab Ab [Presence] in Serum by Immunoassay | Natalizumab Ab |
32597-7 | Natamycin [Susceptibility] | Natamycin |
49487-2 | Nateglinide [Presence] in Serum or Plasma | Nateglinide |
49702-4 | Nateglinide [Mass/volume] in Serum or Plasma | Nateglinide |
52869-5 | None | Nation catchment area |
45952-9 | None | National provider ID |
44763-1 | None | Native inferior vena cava liver graft attachment |
30934-4 | Natriutietic peptide B [Mass/volume] in Serum or Plasma | Natriuretic peptide.B |
35257-5 | Natriutietic peptide B [Mass or Molecules/volume] in Serum or Plasma | Natriuretic peptide.B |
42637-9 | Natriutietic peptide B [Mass/volume] in Blood | Natriuretic peptide.B |
47092-2 | Natriutietic peptide B [Molecules/volume] in Serum or Plasma | Natriuretic peptide.B |
33762-6 | Natriuretic peptide.B prohormone [Mass/volume] in Serum or Plasma | Natriuretic peptide.B prohormone |
33763-4 | Natriuretic peptide.B prohormone [Molecules/volume] in Serum or Plasma | Natriuretic peptide.B prohormone |
34439-0 | Natural killer cell function [Units/volume] in Blood | Natural killer cell function |
53759-7 | Natural killer cell panel in Blood by Flow cytometry (FC) | Natural killer cell panel |
28391-1 | None | Nausea |
42848-2 | None | Nausea |
52872-9 | None | Nautical catchment area |
21716-6 | NB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | NB gene mutation analysis |
22067-3 | NB gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal | NB gene mutations tested for |
48732-2 | NCF1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | NCF1 gene mutation analysis |
48728-0 | NCF1+NCF2+CYBB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Narrative | NCF1+NCF2+CYBB gene mutation analysis |
47966-7 | NCF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Narrative | NCF2 gene mutation analysis |
48733-0 | NCF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | NCF2 gene mutation analysis |
51726-8 | None | NDC labeler code request |
46669-8 | None | Near acuity |
44704-5 | NEB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Narrative | NEB gene mutation analysis |
48793-4 | Necroinflammatory activity grade | Necroinflammatory activity grade |
48792-6 | Necroinflammatory activity score | Necroinflammatory activity score |
28161-8 | None | Need help letting go |
12544-3 | Nefazodone [Mass/volume] in Serum or Plasma | Nefazodone |
17320-3 | Nefazodone [Mass/volume] in Urine | Nefazodone |
25484-7 | Nefazodone [Molecules/volume] in Serum or Plasma | Nefazodone |
34740-1 | NEFL gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Narrative | NEFL gene mutation analysis |
41079-5 | NEFL gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | NEFL gene mutation analysis |
28305-1 | None | Neglect.behavior |
28426-5 | None | Neglect.behavior |
46837-1 | None | Neglect.behavior |
28306-9 | None | Neglect.knowledge |
28443-0 | None | Neglect.knowledge |
46838-9 | None | Neglect.knowledge |
28307-7 | None | Neglect.status |
28444-8 | None | Neglect.status |
46839-7 | None | Neglect.status |
28223-6 | None | Neighborhood &or workplace safety.behavior |
28308-5 | None | Neighborhood &or workplace safety.behavior |
46840-5 | None | Neighborhood &or workplace safety.behavior |
28224-4 | None | Neighborhood &or workplace safety.knowledge |
28309-3 | None | Neighborhood &or workplace safety.knowledge |
46841-3 | None | Neighborhood &or workplace safety.knowledge |
28225-1 | None | Neighborhood &or workplace safety.status |
28310-1 | None | Neighborhood &or workplace safety.status |
46842-1 | None | Neighborhood &or workplace safety.status |
52862-0 | None | Neighborhood catchment area |
14127-5 | Neisseria gonorrhoeae [Presence] in Anal by Organism specific culture | Neisseria gonorrhoeae |
30099-6 | Neisseria gonorrhoeae [Presence] in Conjunctival specimen by Organism specific culture | Neisseria gonorrhoeae |
688-2 | Neisseria gonorrhoeae [Presence] in Cervix by Organism specific culture | Neisseria gonorrhoeae |
689-0 | None | Neisseria gonorrhoeae |
690-8 | Neisseria gonorrhoeae [Presence] in Endometrium by Organism specific culture | Neisseria gonorrhoeae |
691-6 | Neisseria gonorrhoeae [Presence] in Genital specimen by Organism specific culture | Neisseria gonorrhoeae |
692-4 | Neisseria gonorrhoeae [Presence] in Genital lochia by Organism specific culture | Neisseria gonorrhoeae |
693-2 | Neisseria gonorrhoeae [Presence] in Vaginal fluid by Organism specific culture | Neisseria gonorrhoeae |
694-0 | Neisseria gonorrhoeae [Presence] in Semen by Organism specific culture | Neisseria gonorrhoeae |
695-7 | Neisseria gonorrhoeae [Presence] in Synovial fluid by Organism specific culture | Neisseria gonorrhoeae |
696-5 | Neisseria gonorrhoeae [Presence] in Throat by Organism specific culture | Neisseria gonorrhoeae |
697-3 | Neisseria gonorrhoeae [Presence] in Urethra by Organism specific culture | Neisseria gonorrhoeae |
698-1 | Neisseria gonorrhoeae [Presence] in Unspecified specimen by Organism specific culture | Neisseria gonorrhoeae |
22430-3 | Neisseria gonorrhoeae Ab [Titer] in Serum | Neisseria gonorrhoeae Ab |
27021-5 | Neisseria gonorrhoeae Ab [Titer] in Cerebral spinal fluid by Complement fixation | Neisseria gonorrhoeae Ab |
31525-9 | Neisseria gonorrhoeae Ab [Units/volume] in Cerebral spinal fluid | Neisseria gonorrhoeae Ab |
32704-9 | Neisseria gonorrhoeae Ab [Presence] in Serum | Neisseria gonorrhoeae Ab |
42987-8 | Neisseria gonorrhoeae Ab [Titer] in Cerebral spinal fluid | Neisseria gonorrhoeae Ab |
5261-3 | Neisseria gonorrhoeae Ab [Units/volume] in Serum | Neisseria gonorrhoeae Ab |
9568-7 | Neisseria gonorrhoeae Ab [Titer] in Serum by Complement fixation | Neisseria gonorrhoeae Ab |
53762-1 | Neisseria gonorrhoeae IgG Ab [Titer] in Serum | Neisseria gonorrhoeae Ab.IgG |
29311-8 | Neisseria gonorrhoeae Ag [Presence] in Unspecified specimen by Immunofluorescence | Neisseria gonorrhoeae Ag |
31905-3 | Neisseria gonorrhoeae Ag [Presence] in Genital specimen | Neisseria gonorrhoeae Ag |
31906-1 | Neisseria gonorrhoeae Ag [Presence] in Unspecified specimen | Neisseria gonorrhoeae Ag |
6487-3 | Neisseria gonorrhoeae Ag [Presence] in Genital specimen by Immunoassay | Neisseria gonorrhoeae Ag |
6488-1 | Neisseria gonorrhoeae Ag [Presence] in Genital specimen by Immunofluorescence | Neisseria gonorrhoeae Ag |
6489-9 | Neisseria gonorrhoeae Ag [Presence] in Genital specimen by Latex agglutination | Neisseria gonorrhoeae Ag |
6490-7 | Neisseria gonorrhoeae Ag [Presence] in Urethra | Neisseria gonorrhoeae Ag |
21414-8 | Neisseria gonorrhoeae DNA [Presence] in Cervical mucus by Probe & target amplification method | Neisseria gonorrhoeae DNA |
21415-5 | Neisseria gonorrhoeae DNA [Presence] in Urethra by Probe & target amplification method | Neisseria gonorrhoeae DNA |
21416-3 | Neisseria gonorrhoeae DNA [Presence] in Urine by Probe & target amplification method | Neisseria gonorrhoeae DNA |
24111-7 | Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by Probe & target amplification method | Neisseria gonorrhoeae DNA |
32705-6 | Neisseria gonorrhoeae DNA [Presence] in Vaginal fluid by Probe & target amplification method | Neisseria gonorrhoeae DNA |
35735-0 | Neisseria gonorrhoeae DNA [Presence] in Conjunctival specimen by Probe & target amplification method | Neisseria gonorrhoeae DNA |
43403-5 | Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by Probe & signal amplification method | Neisseria gonorrhoeae DNA |
47387-6 | Neisseria gonorrhoeae DNA [Presence] in Genital specimen by Probe & target amplification method | Neisseria gonorrhoeae DNA |
50326-8 | Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen from donor by Probe & target amplification method | Neisseria gonorrhoeae DNA |
23908-7 | None | Neisseria gonorrhoeae rRNA |
32198-4 | Neisseria gonorrhoeae rRNA [Presence] in Cervix by DNA probe | Neisseria gonorrhoeae rRNA |
32199-2 | Neisseria gonorrhoeae rRNA [Presence] in Urethra by DNA probe | Neisseria gonorrhoeae rRNA |
33904-4 | Neisseria gonorrhoeae rRNA [Presence] in Conjunctival specimen by DNA probe | Neisseria gonorrhoeae rRNA |
39557-4 | None | Neisseria gonorrhoeae rRNA |
43305-2 | Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen by Probe & target amplification method | Neisseria gonorrhoeae rRNA |
5028-6 | Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen by DNA probe | Neisseria gonorrhoeae rRNA |
50388-8 | Neisseria gonorrhoeae rRNA [Presence] in Cervix by Probe & target amplification method | Neisseria gonorrhoeae rRNA |
50412-6 | Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen from donor by Probe & target amplification method | Neisseria gonorrhoeae rRNA |
53878-5 | Neisseria gonorrhoeae rRNA [Presence] in Penis by Probe & target amplification method | Neisseria gonorrhoeae rRNA |
53879-3 | Neisseria gonorrhoeae rRNA [Presence] in Vaginal fluid by Probe & target amplification method | Neisseria gonorrhoeae rRNA |
53927-0 | Neisseria gonorrhoeae rRNA [Presence] in Urethra by Probe & target amplification method | Neisseria gonorrhoeae rRNA |
6491-5 | None | Neisseria gonorrhoeae rRNA |
24019-2 | None | Neisseria meningitdis B Ag |
16134-9 | Neisseria meningitidis [Presence] in Unspecified specimen by Organism specific culture | Neisseria meningitidis |
44093-3 | Neisseria meningitidis [Identifier] in Isolate by Organism specific culture | Neisseria meningitidis |
45183-1 | Neisseria meningitidis [Identifier] in Isolate by Agglutination | Neisseria meningitidis |
13271-2 | Neisseria meningitidis A Ab [Units/volume] in Serum | Neisseria meningitidis A Ab |
28546-0 | Neisseria meningitidis A IgG Ab [Mass/volume] in Serum by Immunoassay | Neisseria meningitidis A Ab.IgG |
31526-7 | Neisseria meningitidis A IgG Ab [Units/volume] in Serum | Neisseria meningitidis A Ab.IgG |
42986-0 | Neisseria meningitidis A IgG Ab [Mass/volume] in Serum | Neisseria meningitidis A Ab.IgG |
17326-0 | Neisseria meningitidis A Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | Neisseria meningitidis A Ag |
30094-7 | Neisseria meningitidis A Ag [Presence] in Unspecified specimen by Latex agglutination | Neisseria meningitidis A Ag |
31907-9 | Neisseria meningitidis A Ag [Presence] in Cerebral spinal fluid | Neisseria meningitidis A Ag |
31908-7 | Neisseria meningitidis A Ag [Presence] in Unspecified specimen | Neisseria meningitidis A Ag |
42369-9 | Neisseria meningitidis A Ag [Presence] in Isolate by Agglutination | Neisseria meningitidis A Ag |
6493-1 | Neisseria meningitidis A Ag [Presence] in Cerebral spinal fluid by Immunoassay | Neisseria meningitidis A Ag |
6494-9 | Neisseria meningitidis A Ag [Presence] in Cerebral spinal fluid by Latex agglutination | Neisseria meningitidis A Ag |
6495-6 | Neisseria meningitidis A Ag [Presence] in Unspecified specimen by Immunofluorescence | Neisseria meningitidis A Ag |
41844-2 | Neisseria meningitidis A+B+C+W135+Y+Escherichia coli K1 Ag [Presence] in Serum by Agglutination | Neisseria meningitidis A+B+C+w135+Y+Escherichia coli K1 Ag |
41845-9 | Neisseria meningitidis A+B+C+W135+Y+Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid by Agglutination | Neisseria meningitidis A+B+C+w135+Y+Escherichia coli K1 Ag |
41846-7 | Neisseria meningitidis A+B+C+W135+Y+Escherichia coli K1 Ag [Presence] in Urine by Agglutination | Neisseria meningitidis A+B+C+w135+Y+Escherichia coli K1 Ag |
19133-8 | Neisseria meningitidis A+C+W135+Y Ag [Presence] in Cerebral spinal fluid by Latex agglutination | Neisseria meningitidis A+C+w135+Y Ag |
19259-1 | Neisseria meningitidis A+C+W135+Y Ag [Presence] in Unspecified specimen by Latex agglutination | Neisseria meningitidis A+C+w135+Y Ag |
31909-5 | Neisseria meningitidis A+C+W135+Y Ag [Presence] in Cerebral spinal fluid | Neisseria meningitidis A+C+w135+Y Ag |
31910-3 | Neisseria meningitidis A+C+W135+Y Ag [Presence] in Unspecified specimen | Neisseria meningitidis A+C+w135+Y Ag |
32706-4 | Neisseria meningitidis A+C+W135+Y Ag [Presence] in Urine | Neisseria meningitidis A+C+w135+Y Ag |
33396-3 | Neisseria meningitidis A+C+W135+Y Ag [Presence] in Serum | Neisseria meningitidis A+C+w135+Y Ag |
33397-1 | Neisseria meningitidis A+C+W135+Y Ag [Presence] in Serum by Latex agglutination | Neisseria meningitidis A+C+w135+Y Ag |
33398-9 | Neisseria meningitidis A+C+W135+Y Ag [Presence] in Urine by Latex agglutination | Neisseria meningitidis A+C+w135+Y Ag |
42341-8 | Neisseria meningitidis A+W135 Ag [Presence] in Body fluid | Neisseria meningitidis A+w135 Ag |
17321-1 | Neisseria meningitidis A+Y Ag [Presence] in Urine | Neisseria meningitidis A+Y Ag |
20487-5 | Neisseria meningitidis A+Y Ag [Presence] in Cerebral spinal fluid | Neisseria meningitidis A+Y Ag |
32848-4 | Neisseria meningitidis A+Y Ag [Presence] in Unspecified specimen | Neisseria meningitidis A+Y Ag |
32851-8 | Neisseria meningitidis A+Y Ag [Presence] in Unspecified specimen by Latex agglutination | Neisseria meningitidis A+Y Ag |
17322-9 | Neisseria meningitidis Ab [Presence] in Serum | Neisseria meningitidis Ab |
17323-7 | Neisseria meningitidis Ag [Presence] in Urine | Neisseria meningitidis Ag |
17324-5 | Neisseria meningitidis Ag [Units/volume] in Cerebral spinal fluid by Latex agglutination | Neisseria meningitidis Ag |
31911-1 | Neisseria meningitidis Ag [Units/volume] in Cerebral spinal fluid | Neisseria meningitidis Ag |
31912-9 | Neisseria meningitidis Ag [Presence] in Unspecified specimen | Neisseria meningitidis Ag |
6492-3 | Neisseria meningitidis Ag [Presence] in Unspecified specimen by Immunofluorescence | Neisseria meningitidis Ag |
6508-6 | Neisseria meningitidis Ag [Presence] in Cerebral spinal fluid | Neisseria meningitidis Ag |
50607-1 | Neisseria meningitidis Ag panel in Unspecified specimen by Latex agglutination | Neisseria meningitidis Ag panel |
17327-8 | Neisseria meningitidis B Ab [Units/volume] in Serum | Neisseria meningitidis B Ab |
17328-6 | Neisseria meningitidis B Ag [Presence] in Urine by Latex agglutination | Neisseria meningitidis B Ag |
24017-6 | Neisseria meningitidis B Ag [Presence] in Cerebral spinal fluid | Neisseria meningitidis B Ag |
24018-4 | Neisseria meningitidis B Ag [Presence] in Urine | Neisseria meningitidis B Ag |
30095-4 | Neisseria meningitidis B Ag [Presence] in Unspecified specimen by Latex agglutination | Neisseria meningitidis B Ag |
31913-7 | Neisseria meningitidis B Ag [Presence] in Unspecified specimen | Neisseria meningitidis B Ag |
41503-4 | Neisseria meningitidis B Ag [Presence] in Body fluid | Neisseria meningitidis B Ag |
42370-7 | Neisseria meningitidis B Ag [Presence] in Isolate by Agglutination | Neisseria meningitidis B Ag |
43430-8 | Neisseria meningitidis B Ag [Presence] in Serum | Neisseria meningitidis B Ag |
6496-4 | Neisseria meningitidis B Ag [Presence] in Cerebral spinal fluid by Immunoassay | Neisseria meningitidis B Ag |
6497-2 | Neisseria meningitidis B Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | Neisseria meningitidis B Ag |
6498-0 | Neisseria meningitidis B Ag [Presence] in Cerebral spinal fluid by Latex agglutination | Neisseria meningitidis B Ag |
19134-6 | Neisseria meningitidis B+Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid by Latex agglutination | Neisseria meningitidis B+Escherichia coli K1 Ag |
19260-9 | Neisseria meningitidis B+Escherichia coli K1 Ag [Presence] in Unspecified specimen by Latex agglutination | Neisseria meningitidis B+Escherichia coli K1 Ag |
31914-5 | Neisseria meningitidis B+Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid | Neisseria meningitidis B+Escherichia coli K1 Ag |
31915-2 | Neisseria meningitidis B+Escherichia coli K1 Ag [Presence] in Unspecified specimen | Neisseria meningitidis B+Escherichia coli K1 Ag |
32707-2 | Neisseria meningitidis B+Escherichia coli K1 Ag [Presence] in Urine | Neisseria meningitidis B+Escherichia coli K1 Ag |
33399-7 | Neisseria meningitidis B+Escherichia coli K1 Ag [Presence] in Serum | Neisseria meningitidis B+Escherichia coli K1 Ag |
33400-3 | Neisseria meningitidis B+Escherichia coli K1 Ag [Presence] in Serum by Latex agglutination | Neisseria meningitidis B+Escherichia coli K1 Ag |
33401-1 | Neisseria meningitidis B+Escherichia coli K1 Ag [Presence] in Urine by Latex agglutination | Neisseria meningitidis B+Escherichia coli K1 Ag |
13272-0 | Neisseria meningitidis C Ab [Units/volume] in Serum | Neisseria meningitidis C Ab |
28547-8 | Neisseria meningitidis C IgG Ab [Mass/volume] in Serum by Immunoassay | Neisseria meningitidis C Ab.IgG |
31527-5 | Neisseria meningitidis C IgG Ab [Units/volume] in Serum | Neisseria meningitidis C Ab.IgG |
42985-2 | Neisseria meningitidis C IgG Ab [Mass/volume] in Serum | Neisseria meningitidis C Ab.IgG |
17329-4 | Neisseria meningitidis C Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | Neisseria meningitidis C Ag |
30096-2 | Neisseria meningitidis C Ag [Presence] in Unspecified specimen by Latex agglutination | Neisseria meningitidis C Ag |
31916-0 | Neisseria meningitidis C Ag [Presence] in Cerebral spinal fluid | Neisseria meningitidis C Ag |
31917-8 | Neisseria meningitidis C Ag [Presence] in Unspecified specimen | Neisseria meningitidis C Ag |
42371-5 | Neisseria meningitidis C Ag [Presence] in Isolate by Agglutination | Neisseria meningitidis C Ag |
6499-8 | Neisseria meningitidis C Ag [Presence] in Cerebral spinal fluid by Immunoassay | Neisseria meningitidis C Ag |
6500-3 | Neisseria meningitidis C Ag [Presence] in Cerebral spinal fluid by Latex agglutination | Neisseria meningitidis C Ag |
6501-1 | Neisseria meningitidis C Ag [Presence] in Unspecified specimen by Immunofluorescence | Neisseria meningitidis C Ag |
17325-2 | Neisseria meningitidis C+W135 Ag [Presence] in Urine | Neisseria meningitidis C+w135 Ag |
19022-3 | Neisseria meningitidis C+W135 Ag [Presence] in Cerebral spinal fluid | Neisseria meningitidis C+w135 Ag |
32800-5 | Neisseria meningitidis C+W135 Ag [Presence] in Unspecified specimen by Latex agglutination | Neisseria meningitidis C+w135 Ag |
32841-9 | Neisseria meningitidis C+W135 Ag [Presence] in Unspecified specimen | Neisseria meningitidis C+w135 Ag |
42372-3 | Neisseria meningitidis D Ag [Presence] in Isolate by Agglutination | Neisseria meningitidis D Ag |
49671-1 | Neisseria meningitidis DNA [Presence] in Unspecified specimen by Probe & target amplification method | Neisseria meningitidis DNA |
53606-0 | Neisseria meningitidis DNA [Presence] in Blood by Probe & target amplification method | Neisseria meningitidis DNA |
17331-0 | Neisseria meningitidis polyvalent Ab [Units/volume] in Serum | Neisseria meningitidis polyvalent Ab |
17332-8 | Neisseria meningitidis polyvalent Ag [Presence] in Cerebral spinal fluid | Neisseria meningitidis polyvalent Ag |
5029-4 | Neisseria meningitidis rRNA [Presence] in Unspecified specimen by DNA probe | Neisseria meningitidis rRNA |
6509-4 | Neisseria meningitidis rRNA [Presence] in Cerebral spinal fluid by DNA probe | Neisseria meningitidis rRNA |
49722-2 | Neisseria meningitidis type [Identifier] in Isolate by Agglutination | Neisseria meningitidis type |
39610-1 | Neisseria meningitidis w135 Ab [Mass/volume] in Serum | Neisseria meningitidis w135 Ab |
17333-6 | Neisseria meningitidis w135 Ag [Presence] in Serum or Plasma by Latex agglutination | Neisseria meningitidis w135 Ag |
30097-0 | Neisseria meningitidis w135 Ag [Presence] in Unspecified specimen by Latex agglutination | Neisseria meningitidis w135 Ag |
31918-6 | Neisseria meningitidis w135 Ag [Presence] in Cerebral spinal fluid | Neisseria meningitidis w135 Ag |
31919-4 | Neisseria meningitidis w135 Ag [Presence] in Serum or Plasma | Neisseria meningitidis w135 Ag |
31920-2 | Neisseria meningitidis w135 Ag [Presence] in Unspecified specimen | Neisseria meningitidis w135 Ag |
42368-1 | Neisseria meningitidis w135 Ag [Presence] in Isolate by Agglutination | Neisseria meningitidis w135 Ag |
6506-0 | Neisseria meningitidis w135 Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | Neisseria meningitidis w135 Ag |
6507-8 | Neisseria meningitidis w135 Ag [Presence] in Cerebral spinal fluid by Latex agglutination | Neisseria meningitidis w135 Ag |
42373-1 | Neisseria meningitidis X Ag [Presence] in Isolate by Agglutination | Neisseria meningitidis X Ag |
22431-1 | Neisseria meningitidis Y Ab [Titer] in Unspecified specimen | Neisseria meningitidis Y Ab |
31528-3 | Neisseria meningitidis Y Ab [Units/volume] in Unspecified specimen | Neisseria meningitidis Y Ab |
39618-4 | Neisseria meningitidis Y Ab [Mass/volume] in Serum | Neisseria meningitidis Y Ab |
6502-9 | Neisseria meningitidis Y Ab [Titer] in Unspecified specimen by Immunofluorescence | Neisseria meningitidis Y Ab |
7972-3 | Neisseria meningitidis Y Ab [Presence] in Unspecified specimen | Neisseria meningitidis Y Ab |
17330-2 | Neisseria meningitidis Y Ag [Presence] in Cerebral spinal fluid | Neisseria meningitidis Y Ag |
30098-8 | Neisseria meningitidis Y Ag [Presence] in Unspecified specimen by Latex agglutination | Neisseria meningitidis Y Ag |
31921-0 | Neisseria meningitidis Y Ag [Presence] in Unspecified specimen | Neisseria meningitidis Y Ag |
42374-9 | Neisseria meningitidis Y Ag [Presence] in Isolate by Agglutination | Neisseria meningitidis Y Ag |
6503-7 | Neisseria meningitidis Y Ag [Presence] in Cerebral spinal fluid by Immunoassay | Neisseria meningitidis Y Ag |
6504-5 | Neisseria meningitidis Y Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | Neisseria meningitidis Y Ag |
6505-2 | Neisseria meningitidis Y Ag [Presence] in Cerebral spinal fluid by Latex agglutination | Neisseria meningitidis Y Ag |
42375-6 | Neisseria meningitidis Z Ag [Presence] in Isolate by Agglutination | Neisseria meningitidis Z Ag |
42376-4 | Neisseria meningitidis Z' Ag [Presence] in Isolate by Agglutination | Neisseria meningitidis Z' Ag |
43383-9 | Neisseria sp identified in Throat by Organism specific culture | Neisseria sp identified |
43384-7 | Neisseria sp identified in Urethra by Organism specific culture | Neisseria sp identified |
43385-4 | Neisseria sp identified in Cervix by Organism specific culture | Neisseria sp identified |
43386-2 | Neisseria sp identified in Anal by Organism specific culture | Neisseria sp identified |
43387-0 | Neisseria sp identified in Unspecified specimen by Organism specific culture | Neisseria sp identified |
29120-3 | Nelfinavir [Units/volume] in Serum or Plasma | Nelfinavir |
30280-2 | Nelfinavir [Susceptibility] by Phenotype method | Nelfinavir |
30294-3 | Nelfinavir [Susceptibility] by Genotype method | Nelfinavir |
30309-9 | Nelfinavir [Susceptibility] | Nelfinavir |
32647-0 | Nelfinavir [Mass/volume] in Serum or Plasma | Nelfinavir |
35113-0 | Nelfinavir M8 [Mass/volume] in Serum or Plasma | Nelfinavir M8 |
51923-1 | Nelfinavir [Mass/volume] in Serum or Plasma --peak | Nelfinavir^peak |
10995-9 | Neomycin [Mass/volume] in Serum or Plasma | Neomycin |
18953-0 | Neomycin [Susceptibility] | Neomycin |
25262-7 | Neomycin [Mass/volume] in Unspecified specimen | Neomycin |
354-1 | Neomycin [Susceptibility] by Minimum lethal concentration (MLC) | Neomycin |
355-8 | Neomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Neomycin |
356-6 | Neomycin [Susceptibility] by Disk diffusion (KB) | Neomycin |
357-4 | Neomycin [Susceptibility] by Serum bactericidal titer | Neomycin |
41705-5 | Neomycin [Susceptibility] by Gradient strip (E-test) | Neomycin |
50189-0 | Neonatal bilirubin panel [Mass/volume] in Serum or Plasma | Neonatal bilirubin panel |
29750-7 | Neonatal intensive care records | Neonatal intensive care records |
34146-1 | Neopterin [Molecules/volume] in Cerebral spinal fluid | Neopterin |
34908-4 | Neopterin [Mass/volume] in Serum or Plasma | Neopterin |
35259-1 | Neopterin [Mass or Molecules/volume] in Serum or Plasma | Neopterin |
3847-1 | Neopterin [Mass/volume] in Urine | Neopterin |
4346-3 | Neopterin [Mass] of Dose | Neopterin |
9740-2 | Neopterin [Molecules/volume] in Serum or Plasma | Neopterin |
32332-9 | Neopterin/Biopterin [Molecular ratio] in Urine | Neopterin/Biopterin |
17334-4 | Neopterin/Creatinine [Mass ratio] in Urine | Neopterin/Creatinine |
47711-7 | Neopterin/Creatinine [Molecular ratio] in Urine | Neopterin/Creatinine |
48874-2 | Neorickettsia sp [Presence] in Unspecified specimen by Organism specific culture | Neorickettsia sp |
15492-2 | Neospora caninum Ab [Presence] in Serum by Immunoassay | Neospora caninum Ab |
20904-9 | Neospora caninum Ab [Presence] in Serum by Immunofluorescence | Neospora caninum Ab |
22432-9 | Neospora caninum Ab [Presence] in Serum | Neospora caninum Ab |
22433-7 | None | Neospora caninum Ab |
23756-0 | Neospora caninum Ab [Units/volume] in Serum by Immunoassay | Neospora caninum Ab |
23757-8 | Neospora caninum Ab [Titer] in Serum by Immunofluorescence | Neospora caninum Ab |
23758-6 | Neospora caninum Ab [Titer] in Serum | Neospora caninum Ab |
31529-1 | Neospora caninum Ab [Units/volume] in Serum | Neospora caninum Ab |
23759-4 | Neospora caninum Ag [Presence] in Tissue by Immune stain | Neospora caninum Ag |
23760-2 | Neospora caninum Ag [Presence] in Fixed tissue by Immune stain | Neospora caninum Ag |
17335-1 | Neostigmine [Mass/volume] in Serum or Plasma | Neostigmine |
35170-0 | Nervonate (C24:1) [Molecules/volume] in Serum or Plasma | Nervonate |
18954-8 | Netilmicin [Susceptibility] | Netilmicin |
25263-5 | Netilmicin [Mass/volume] in Unspecified specimen | Netilmicin |
358-2 | Netilmicin [Susceptibility] by Minimum lethal concentration (MLC) | Netilmicin |
359-0 | Netilmicin [Susceptibility] by Minimum inhibitory concentration (MIC) | Netilmicin |
360-8 | Netilmicin [Susceptibility] by Disk diffusion (KB) | Netilmicin |
361-6 | Netilmicin [Susceptibility] by Serum bactericidal titer | Netilmicin |
4347-1 | Netilmicin [Mass] of Dose | Netilmicin |
47385-0 | Netilmicin [Mass/volume] in Serum or Plasma | Netilmicin |
7035-9 | Netilmicin [Susceptibility] by Gradient strip (E-test) | Netilmicin |
3848-9 | Netilmicin [Mass/volume] in Serum or Plasma --peak | Netilmicin^peak |
3849-7 | Netilmicin [Mass/volume] in Serum or Plasma --random | Netilmicin^random |
3850-5 | Netilmicin [Mass/volume] in Serum or Plasma --trough | Netilmicin^trough |
50327-6 | Neu-N Ag [Presence] in Tissue by Immune stain | Neu-N Ag |
48803-1 | Neural tube defect risk [Finding] in fetus | Neural tube defect risk |
49838-6 | Neural tube defect risk [Finding] in population | Neural tube defect risk |
49091-2 | Neural tube defect risk based on maternal age [Finding] in fetus | Neural tube defect risk based on maternal age |
49584-6 | Neural tube defect risk cutoff [Finding] in fetus | Neural tube defect risk cutoff |
28311-9 | None | Neuro-musculo-skeletal function.behavior |
28474-5 | None | Neuro-musculo-skeletal function.behavior |
46843-9 | None | Neuro-musculo-skeletal function.behavior |
28312-7 | None | Neuro-musculo-skeletal function.knowledge |
28475-2 | None | Neuro-musculo-skeletal function.knowledge |
46844-7 | None | Neuro-musculo-skeletal function.knowledge |
28313-5 | None | Neuro-musculo-skeletal function.status |
28476-0 | None | Neuro-musculo-skeletal function.status |
46845-4 | None | Neuro-musculo-skeletal function.status |
47034-4 | Neurofilament Ag [Presence] in Tissue by Immune stain | Neurofilament Ag |
21417-1 | Neurokinin A [Units/volume] in Serum or Plasma | Neurokinin A |
49728-9 | Neurokinin A [Mass/volume] in Serum or Plasma | Neurokinin A |
39262-1 | None | Neurologic screen assessment |
39199-5 | None | Neurologic screen finding recency |
39198-7 | None | Neurologic screen follow-up status |
39197-9 | None | Neurologic screen results indicator |
46023-8 | None | Neurological diseases or conditions |
27897-8 | Neuromuscular electrophysiology studies (set) | Neuromuscular electrophysiology studies |
43638-6 | Neuromyelitis optica IgG Ab [Presence] in Serum or Plasma | Neuromyelitis optica Ab.IgG |
43752-5 | Neuromyelitis optica IgG Ab [Units/volume] in Serum or Plasma by Immunofluorescence | Neuromyelitis optica Ab.IgG |
44794-6 | Neuromyelitis optica IgG Ab [Titer] in Serum or Plasma by Immunofluorescence | Neuromyelitis optica Ab.IgG |
46718-3 | Neuromyelitis optica IgG Ab [Presence] in Cerebral spinal fluid | Neuromyelitis optica Ab.IgG |
17336-9 | Neuronal Ab [Presence] in Serum by Immunofluorescence | Neuronal Ab |
17337-7 | Neuronal Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | Neuronal Ab |
17338-5 | Neuronal Ab [Units/volume] in Serum by Immunofluorescence | Neuronal Ab |
17339-3 | Neuronal Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence | Neuronal Ab |
31530-9 | Neuronal Ab [Units/volume] in Cerebral spinal fluid | Neuronal Ab |
31531-7 | Neuronal Ab [Presence] in Cerebral spinal fluid | Neuronal Ab |
31532-5 | Neuronal Ab [Units/volume] in Serum | Neuronal Ab |
31533-3 | Neuronal Ab [Presence] in Serum | Neuronal Ab |
32853-4 | Neuronal Ab [Units/volume] in Serum by Immunoassay | Neuronal Ab |
17340-1 | Neuronal IgG Ab [Presence] in Body fluid by Immunoassay | Neuronal Ab.IgG |
31534-1 | Neuronal IgG Ab [Presence] in Body fluid | Neuronal Ab.IgG |
33418-5 | Neuronal IgG Ab [Presence] in Serum | Neuronal Ab.IgG |
11088-2 | Neuronal nuclear Ab [Presence] in Serum | Neuronal nuclear Ab |
11089-0 | Neuronal nuclear Ab [Presence] in Cerebral spinal fluid | Neuronal nuclear Ab |
14240-6 | Neuronal nuclear Ab [Units/volume] in Cerebral spinal fluid | Neuronal nuclear Ab |
15398-1 | Neuronal nuclear Ab [Titer] in Serum | Neuronal nuclear Ab |
16139-8 | Neuronal nuclear Ab [Titer] in Cerebral spinal fluid | Neuronal nuclear Ab |
17341-9 | Neuronal nuclear Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | Neuronal nuclear Ab |
19137-9 | Neuronal nuclear Ab [Units/volume] in Serum by Immunoblot (IB) | Neuronal nuclear Ab |
31535-8 | Neuronal nuclear Ab [Units/volume] in Serum | Neuronal nuclear Ab |
33600-8 | Neuronal nuclear Ab [Units/volume] in Serum by Immunofluorescence | Neuronal nuclear Ab |
35278-1 | Neuronal nuclear Ab [Presence] in Serum by Immunoblot (IB) | Neuronal nuclear Ab |
49738-8 | Neuronal nuclear Ab [Presence] in Serum by Immunofluorescence | Neuronal nuclear Ab |
15399-9 | Neuronal nuclear IgG Ab [Units/volume] in Serum by Immunofluorescence | Neuronal nuclear Ab.IgG |
31536-6 | Neuronal nuclear IgG Ab [Units/volume] in Serum | Neuronal nuclear Ab.IgG |
33590-1 | Neuronal nuclear IgG Ab [Units/volume] in Cerebral spinal fluid | Neuronal nuclear Ab.IgG |
33591-9 | Neuronal nuclear IgG Ab [Units/volume] in Serum by Flow cytometry (FC) | Neuronal nuclear Ab.IgG |
44770-6 | Neuronal nuclear IgG Ab [Titer] in Serum by Immunofluorescence | Neuronal nuclear Ab.IgG |
48405-5 | Neuronal nuclear IgG Ab [Presence] in Serum by Immunofluorescence | Neuronal nuclear Ab.IgG |
12854-6 | Neuronal nuclear type 1 Ab [Units/volume] in Serum | Neuronal nuclear type 1 Ab |
13115-1 | None | Neuronal nuclear type 1 Ab |
13997-2 | Neuronal nuclear type 1 Ab [Titer] in Serum | Neuronal nuclear type 1 Ab |
24400-4 | Neuronal nuclear type 1 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | Neuronal nuclear type 1 Ab |
24403-8 | Neuronal nuclear type 1 Ab [Titer] in Cerebral spinal fluid by Immunoblot (IB) | Neuronal nuclear type 1 Ab |
31537-4 | Neuronal nuclear type 1 Ab [Units/volume] in Cerebral spinal fluid | Neuronal nuclear type 1 Ab |
33615-6 | Neuronal nuclear type 1 Ab [Presence] in Serum | Neuronal nuclear type 1 Ab |
41769-1 | Neuronal nuclear type 1 Ab [Presence] in Serum by Immunoblot (IB) | Neuronal nuclear type 1 Ab |
44768-0 | Neuronal nuclear type 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | Neuronal nuclear type 1 Ab |
44769-8 | Neuronal nuclear type 1 Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) | Neuronal nuclear type 1 Ab |
53711-8 | Neuronal nuclear type 1 Ab [Titer] in Cerebral spinal fluid | Neuronal nuclear type 1 Ab |
13114-4 | None | Neuronal nuclear type 2 Ab |
13998-0 | Neuronal nuclear type 2 Ab [Titer] in Serum | Neuronal nuclear type 2 Ab |
17342-7 | Neuronal nuclear type 2 Ab [Units/volume] in Serum | Neuronal nuclear type 2 Ab |
17343-5 | Neuronal nuclear type 2 Ab [Presence] in Cerebral spinal fluid | Neuronal nuclear type 2 Ab |
17344-3 | Neuronal nuclear type 2 Ab [Units/volume] in Serum by Immunofluorescence | Neuronal nuclear type 2 Ab |
24401-2 | Neuronal nuclear type 2 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | Neuronal nuclear type 2 Ab |
24404-6 | Neuronal nuclear type 2 Ab [Titer] in Cerebral spinal fluid by Immunoblot (IB) | Neuronal nuclear type 2 Ab |
31538-2 | Neuronal nuclear type 2 Ab [Units/volume] in Cerebral spinal fluid | Neuronal nuclear type 2 Ab |
31539-0 | Neuronal nuclear type 2 Ab [Presence] in Serum | Neuronal nuclear type 2 Ab |
33008-4 | Neuronal nuclear type 2 Ab [Presence] in Serum by Immunoblot (IB) | Neuronal nuclear type 2 Ab |
43187-4 | Neuronal nuclear type 2 Ab [Presence] in Serum by Immunofluorescence | Neuronal nuclear type 2 Ab |
43188-2 | Neuronal nuclear type 2 Ab [Titer] in Serum by Immunofluorescence | Neuronal nuclear type 2 Ab |
53712-6 | Neuronal nuclear type 2 Ab [Titer] in Cerebral spinal fluid | Neuronal nuclear type 2 Ab |
33924-2 | Neuronal nuclear type 3 Ab [Titer] in Serum | Neuronal nuclear type 3 Ab |
35144-5 | Neuronal nuclear type 3 Ab [Titer] in Cerebral spinal fluid | Neuronal nuclear type 3 Ab |
43102-3 | Neuronal nuclear type 3 Ab [Presence] in Serum | Neuronal nuclear type 3 Ab |
28560-1 | Neuronal thread protein [Mass/volume] in Cerebral spinal fluid | Neuronal thread protein |
49866-7 | Neuropeptide Y [Mass/volume] in Serum | Neuropeptide Y |
2654-2 | Neurophysin [Mass/volume] in Serum or Plasma | Neurophysin |
6187-9 | Neurospora sitophila IgE Ab [Units/volume] in Serum | Neurospora sitophila Ab.IgE |
25485-4 | Neurospora sitophila IgE Ab RAST class in Serum | Neurospora sitophila Ab.IgE.RAST class |
2655-9 | Neurotensin [Mass/volume] in Serum | Neurotensin |
17345-0 | None | Neutrophil Ab |
17346-8 | Neutrophil Ab [Presence] in Serum by Immunofluorescence | Neutrophil Ab |
17347-6 | Neutrophil Ab [Units/volume] in Serum by Immunofluorescence | Neutrophil Ab |
21418-9 | Neutrophil Ab [Presence] in Serum | Neutrophil Ab |
39587-1 | Neutrophil Ab [Presence] in Serum by Immunoassay | Neutrophil Ab |
41617-2 | Neutrophil Ab [Presence] in Serum by Flow cytometry (FC) | Neutrophil Ab |
45150-0 | Neutrophil Ab [Units/volume] in Serum by Immunoassay | Neutrophil Ab |
5171-4 | Neutrophil Ab [Units/volume] in Serum | Neutrophil Ab |
17348-4 | Neutrophil IgA Ab [Units/volume] in Serum | Neutrophil Ab.IgA |
17349-2 | Neutrophil IgG Ab [Units/volume] in Serum | Neutrophil Ab.IgG |
17350-0 | Neutrophil IgM Ab [Units/volume] in Serum | Neutrophil Ab.IgM |
24382-4 | Neutrophil associated Ab [Identifier] in Serum | Neutrophil associated Ab |
34971-2 | Neutrophil associated Ab [Presence] in Blood | Neutrophil associated Ab |
11567-5 | None | Neutrophil cytoplasmic Ab |
17351-8 | Neutrophil cytoplasmic Ab [Presence] in Serum | Neutrophil cytoplasmic Ab |
17352-6 | Neutrophil cytoplasmic Ab [interpretation] in Serum | Neutrophil cytoplasmic Ab |
21023-7 | Neutrophil cytoplasmic Ab [Titer] in Serum | Neutrophil cytoplasmic Ab |
35279-9 | Neutrophil cytoplasmic Ab [Presence] in Serum by Immunofluorescence | Neutrophil cytoplasmic Ab |
45151-8 | Neutrophil cytoplasmic Ab [Units/volume] in Serum by Immunoassay | Neutrophil cytoplasmic Ab |
5128-4 | Neutrophil cytoplasmic Ab [Units/volume] in Serum | Neutrophil cytoplasmic Ab |
51924-9 | Neutrophil cytoplasmic Ab [Titer] in Serum by Immunofluorescence | Neutrophil cytoplasmic Ab |
5262-1 | Neutrophil cytoplasmic Ab [Units/volume] in Serum by Immunofluorescence | Neutrophil cytoplasmic Ab |
21419-7 | Neutrophil cytoplasmic Ab pattern [interpretation] in Serum by Immunofluorescence | Neutrophil cytoplasmic Ab pattern |
49308-0 | Neutrophil cytoplasmic Ab pattern [interpretation] in Serum by Immunofluorescence Narrative | Neutrophil cytoplasmic Ab pattern |
17358-3 | Neutrophil Cytoplasmic Ab atypical [Units/volume] in Serum | Neutrophil cytoplasmic Ab.atypical |
29641-8 | Neutrophil Cytoplasmic Ab atypical [Presence] in Serum by Immunofluorescence | Neutrophil cytoplasmic Ab.atypical |
53012-1 | Neutrophil Cytoplasmic Ab atypical [Titer] in Serum by Immunofluorescence | Neutrophil cytoplasmic Ab.atypical |
14277-8 | Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence | Neutrophil cytoplasmic Ab.classic |
17353-4 | Neutrophil cytoplasmic Ab.classic [Presence] in Serum by Immunofluorescence | Neutrophil cytoplasmic Ab.classic |
30538-3 | Neutrophil cytoplasmic Ab.classic [Presence] in Serum | Neutrophil cytoplasmic Ab.classic |
32708-0 | Neutrophil cytoplasmic Ab.classic [Titer] in Serum | Neutrophil cytoplasmic Ab.classic |
37992-5 | Neutrophil cytoplasmic Ab.classic [Units/volume] in Serum by Immunoassay | Neutrophil cytoplasmic Ab.classic |
8084-6 | Neutrophil cytoplasmic Ab.classic [Units/volume] in Serum | Neutrophil cytoplasmic Ab.classic |
29642-6 | Neutrophil cytoplasmic Ab.classic.atypical [Presence] in Serum by Immunofluorescence | Neutrophil cytoplasmic Ab.classic.atypical |
17354-2 | Neutrophil cytoplasmic IgA Ab [Presence] in Serum | Neutrophil cytoplasmic Ab.IgA |
18329-3 | Neutrophil cytoplasmic IgA Ab [Units/volume] in Serum | Neutrophil cytoplasmic Ab.IgA |
17355-9 | Neutrophil cytoplasmic IgG Ab [Presence] in Serum | Neutrophil cytoplasmic Ab.IgG |
18330-1 | Neutrophil cytoplasmic IgG Ab [Units/volume] in Serum | Neutrophil cytoplasmic Ab.IgG |
29967-7 | Neutrophil cytoplasmic IgG Ab [Titer] in Serum by Immunofluorescence | Neutrophil cytoplasmic Ab.IgG |
17356-7 | Neutrophil cytoplasmic IgM Ab [Presence] in Serum | Neutrophil cytoplasmic Ab.IgM |
18331-9 | Neutrophil cytoplasmic IgM Ab [Units/volume] in Serum | Neutrophil cytoplasmic Ab.IgM |
14278-6 | Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence | Neutrophil cytoplasmic Ab.perinuclear |
17357-5 | Neutrophil cytoplasmic Ab.perinuclear [Presence] in Serum by Immunofluorescence | Neutrophil cytoplasmic Ab.perinuclear |
30539-1 | Neutrophil cytoplasmic Ab.perinuclear [Presence] in Serum | Neutrophil cytoplasmic Ab.perinuclear |
32787-4 | Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum | Neutrophil cytoplasmic Ab.perinuclear |
37991-7 | Neutrophil cytoplasmic Ab.perinuclear [Units/volume] in Serum by Immunoassay | Neutrophil cytoplasmic Ab.perinuclear |
8085-3 | Neutrophil cytoplasmic Ab.perinuclear [Units/volume] in Serum | Neutrophil cytoplasmic Ab.perinuclear |
49503-6 | Neutrophil cytoplasmic Ab.perinuclear.atypical [Titer] in Serum by Immunofluorescence | Neutrophil cytoplasmic Ab.perinuclear.atypical |
53029-5 | Neutrophil cytoplasmic Ab.perinuclear.atypical [Presence] in Serum by Immunofluorescence | Neutrophil cytoplasmic Ab.perinuclear.atypical |
30903-9 | Neutrophil oxidative burst [Presence] in Blood by Flow cytometry (FC) | Neutrophil oxidative burst |
43292-2 | Neutrophil oxidative burst/100 cells in Blood | Neutrophil oxidative burst/100 cells |
16290-9 | Neutrophils [Presence] in Stool | Neutrophils |
17359-1 | Neutrophils [#/volume] in Semen by Manual count | Neutrophils |
26499-4 | Neutrophils [#/volume] in Blood | Neutrophils |
26500-9 | Neutrophils [#/volume] in Cerebral spinal fluid | Neutrophils |
26501-7 | Neutrophils [#/volume] in Pleural fluid | Neutrophils |
26502-5 | Neutrophils [#/volume] in Peritoneal fluid | Neutrophils |
26503-3 | Neutrophils [#/volume] in Semen | Neutrophils |
26504-1 | Neutrophils [#/volume] in Synovial fluid | Neutrophils |
30448-5 | Neutrophils [#/volume] in Urine | Neutrophils |
32709-8 | Neutrophils [#/volume] in Body fluid | Neutrophils |
38996-5 | Neutrophils [Presence] in Urine by Light microscopy | Neutrophils |
40566-2 | Neutrophils [#/volume] in Body fluid by Manual count | Neutrophils |
48048-3 | Neutrophils [Presence] in Nose by Wright stain | Neutrophils |
48050-9 | Neutrophils [Presence] in Stool by Wright stain | Neutrophils |
5906-3 | Neutrophils [#/volume] in Synovial fluid by Automated count | Neutrophils |
751-8 | Neutrophils [#/volume] in Blood by Automated count | Neutrophils |
752-6 | None | Neutrophils |
753-4 | Neutrophils [#/volume] in Blood by Manual count | Neutrophils |
754-2 | Neutrophils [#/volume] in Cerebral spinal fluid by Automated count | Neutrophils |
755-9 | Neutrophils [#/volume] in Cerebral spinal fluid by Manual count | Neutrophils |
756-7 | Neutrophils [#/volume] in Pleural fluid by Automated count | Neutrophils |
757-5 | Neutrophils [#/volume] in Pleural fluid by Manual count | Neutrophils |
758-3 | Neutrophils [#/volume] in Peritoneal fluid by Automated count | Neutrophils |
759-1 | Neutrophils [#/volume] in Peritoneal fluid by Manual count | Neutrophils |
760-9 | Neutrophils [#/volume] in Synovial fluid by Manual count | Neutrophils |
761-7 | Neutrophils [#/volume] in Urine by Automated count | Neutrophils |
762-5 | Neutrophils [#/volume] in Urine by Manual count | Neutrophils |
33215-5 | Neutrophils.agranular [Presence] in Blood by Light microscopy | Neutrophils.agranular |
26507-4 | Neutrophils.band form [#/volume] in Blood | Neutrophils.band form |
30229-9 | Neutrophils.band form [#/volume] in Blood by Automated count | Neutrophils.band form |
34524-9 | Neutrophils.band form [Presence] in Blood by Automated count | Neutrophils.band form |
35013-2 | Neutrophils.band form [#/volume] in Synovial fluid | Neutrophils.band form |
35014-0 | Neutrophils.band form [#/volume] in Body fluid | Neutrophils.band form |
35015-7 | Neutrophils.band form [#/volume] in Cerebral spinal fluid | Neutrophils.band form |
40572-0 | Neutrophils.band form [#/volume] in Body fluid by Manual count | Neutrophils.band form |
763-3 | Neutrophils.band form [#/volume] in Blood by Manual count | Neutrophils.band form |
11103-9 | Neutrophils.band form/100 cells in Bone marrow by Microscopy | Neutrophils.band form/100 cells |
12278-8 | Neutrophils.band form/100 leukocytes in Cerebral spinal fluid by Manual count | Neutrophils.band form/100 leukocytes |
13354-6 | Neutrophils.band form/100 leukocytes in Body fluid by Manual count | Neutrophils.band form/100 leukocytes |
26508-2 | Neutrophils.band form/100 leukocytes in Blood | Neutrophils.band form/100 leukocytes |
26509-0 | Neutrophils.band form/100 leukocytes in Cerebral spinal fluid | Neutrophils.band form/100 leukocytes |
26510-8 | Neutrophils.band form/100 leukocytes in Body fluid | Neutrophils.band form/100 leukocytes |
33361-7 | Neutrophils.band form/100 leukocytes in Synovial fluid | Neutrophils.band form/100 leukocytes |
33388-0 | Neutrophils.band form/100 leukocytes in Pericardial fluid | Neutrophils.band form/100 leukocytes |
35332-6 | Neutrophils.band form/100 leukocytes in Blood by Automated count | Neutrophils.band form/100 leukocytes |
764-1 | Neutrophils.band form/100 leukocytes in Blood by Manual count | Neutrophils.band form/100 leukocytes |
30449-3 | Neutrophils.hypersegmented [#/volume] in Blood | Neutrophils.hypersegmented |
34199-0 | Neutrophils.hypersegmented [Presence] in Blood by Automated count | Neutrophils.hypersegmented |
765-8 | Neutrophils.hypersegmented [Presence] in Blood by Light microscopy | Neutrophils.hypersegmented |
766-6 | Neutrophils.hypersegmented [#/volume] in Blood by Manual count | Neutrophils.hypersegmented |
30450-1 | Neutrophils.hypersegmented/100 leukocytes in Blood | Neutrophils.hypersegmented/100 leukocytes |
767-4 | Neutrophils.hypersegmented/100 leukocytes in Blood by Manual count | Neutrophils.hypersegmented/100 leukocytes |
40654-6 | Neutrophils.hypogranulated [Presence] in Blood by Light microscopy | Neutrophils.hypogranulated |
53797-7 | Neutrophils.immature/100 leukocytes in Blood | Neutrophils.immature/100 leukocytes |
30451-9 | Neutrophils.segmented [#/volume] in Blood | Neutrophils.segmented |
30452-7 | Neutrophils.segmented [#/volume] in Body fluid | Neutrophils.segmented |
35009-0 | Neutrophils.segmented [#/volume] in Synovial fluid | Neutrophils.segmented |
35010-8 | Neutrophils.segmented [#/volume] in Peritoneal fluid | Neutrophils.segmented |
35011-6 | Neutrophils.segmented [#/volume] in Cerebral spinal fluid | Neutrophils.segmented |
35012-4 | Neutrophils.segmented [#/volume] in Pleural fluid | Neutrophils.segmented |
6745-4 | Neutrophils.segmented [#/volume] in Body fluid by Manual count | Neutrophils.segmented |
768-2 | Neutrophils.segmented [#/volume] in Blood by Manual count | Neutrophils.segmented |
11128-6 | Neutrophils.segmented/100 cells in Bone marrow | Neutrophils.segmented/100 cells |
14107-7 | Neutrophils.segmented/100 leukocytes in Cerebral spinal fluid by Manual count | Neutrophils.segmented/100 leukocytes |
26505-8 | Neutrophils.segmented/100 leukocytes in Blood | Neutrophils.segmented/100 leukocytes |
26506-6 | Neutrophils.segmented/100 leukocytes in Cerebral spinal fluid | Neutrophils.segmented/100 leukocytes |
30230-7 | Neutrophils.segmented/100 leukocytes in Body fluid by Manual count | Neutrophils.segmented/100 leukocytes |
30453-5 | Neutrophils.segmented/100 leukocytes in Body fluid | Neutrophils.segmented/100 leukocytes |
32200-8 | Neutrophils.segmented/100 leukocytes in Blood by Automated count | Neutrophils.segmented/100 leukocytes |
33384-9 | Neutrophils.segmented/100 leukocytes in Peritoneal fluid | Neutrophils.segmented/100 leukocytes |
33385-6 | Neutrophils.segmented/100 leukocytes in Pleural fluid | Neutrophils.segmented/100 leukocytes |
33386-4 | Neutrophils.segmented/100 leukocytes in Synovial fluid | Neutrophils.segmented/100 leukocytes |
33387-2 | Neutrophils.segmented/100 leukocytes in Pericardial fluid | Neutrophils.segmented/100 leukocytes |
769-0 | Neutrophils.segmented/100 leukocytes in Blood by Manual count | Neutrophils.segmented/100 leukocytes |
18319-4 | Neutrophils.vacuolated [Presence] in Blood by Light microscopy | Neutrophils.vacuolated |
34473-9 | Neutrophils.vacuolated+Segmented [Presence] in Blood | Neutrophils.vacuolated+Segmented |
11115-3 | Neutrophils/100 cells in Bone marrow by Microscopy | Neutrophils/100 cells |
12238-2 | Neutrophils/100 leukocytes in Body fluid by Manual count | Neutrophils/100 leukocytes |
13352-0 | None | Neutrophils/100 leukocytes |
13516-0 | Neutrophils/100 leukocytes in Cerebral spinal fluid by Manual count | Neutrophils/100 leukocytes |
13597-0 | Neutrophils/100 leukocytes in Nose | Neutrophils/100 leukocytes |
13836-2 | Neutrophils/100 leukocytes in Peritoneal fluid by Manual count | Neutrophils/100 leukocytes |
14039-2 | Neutrophils/100 leukocytes in Cerebral spinal fluid by Microscopy | Neutrophils/100 leukocytes |
14847-8 | Neutrophils/100 leukocytes in Pericardial fluid by Manual count | Neutrophils/100 leukocytes |
14848-6 | Neutrophils/100 leukocytes in Pleural fluid by Manual count | Neutrophils/100 leukocytes |
17836-8 | Neutrophils/100 leukocytes in Synovial fluid | Neutrophils/100 leukocytes |
23761-0 | Neutrophils/100 leukocytes in Blood by Manual count | Neutrophils/100 leukocytes |
26511-6 | Neutrophils/100 leukocytes in Blood | Neutrophils/100 leukocytes |
26512-4 | Neutrophils/100 leukocytes in Cerebral spinal fluid | Neutrophils/100 leukocytes |
26513-2 | Neutrophils/100 leukocytes in Body fluid | Neutrophils/100 leukocytes |
26514-0 | Neutrophils/100 leukocytes in Peritoneal fluid | Neutrophils/100 leukocytes |
27930-7 | Neutrophils/100 leukocytes in Bronchial specimen | Neutrophils/100 leukocytes |
27932-3 | Neutrophils/100 leukocytes in Sputum | Neutrophils/100 leukocytes |
30454-3 | Neutrophils/100 leukocytes in Pericardial fluid | Neutrophils/100 leukocytes |
30455-0 | Neutrophils/100 leukocytes in Pleural fluid | Neutrophils/100 leukocytes |
32804-7 | Neutrophils/100 leukocytes in Bronchial specimen by Manual count | Neutrophils/100 leukocytes |
40491-3 | Neutrophils/100 leukocytes in Synovial fluid by Manual count | Neutrophils/100 leukocytes |
40536-5 | Neutrophils/100 leukocytes in Peritoneal dialysis fluid by Manual count | Neutrophils/100 leukocytes |
53520-3 | Neutrophils/100 leukocytes in Dialysis fluid | Neutrophils/100 leukocytes |
770-8 | Neutrophils/100 leukocytes in Blood by Automated count | Neutrophils/100 leukocytes |
29121-1 | Nevirapine [Units/volume] in Serum or Plasma | Nevirapine |
30275-2 | Nevirapine [Susceptibility] by Phenotype method | Nevirapine |
30289-3 | Nevirapine [Susceptibility] by Genotype method | Nevirapine |
30311-5 | Nevirapine [Susceptibility] | Nevirapine |
32646-2 | Nevirapine [Mass/volume] in Serum or Plasma | Nevirapine |
51925-6 | Nevirapine [Mass/volume] in Serum or Plasma --peak | Nevirapine^peak |
18626-2 | Psychiatric rehabilitation treatment plan, new/revised | New &or revised |
27470-4 | Skilled nursing treatment plan, new/revised | New &or revised |
27474-6 | Alcohol-substance abuse rehabilitation treatment plan, new/revised | New &or revised |
27483-7 | Cardiac rehabilitation treatment plan, new/revised | New &or revised |
27597-4 | Occupational therapy treatment plan, new/revised | New &or revised |
27660-0 | Physical therapy treatment plan, new/revised | New &or revised |
27699-8 | Respiratory therapy treatment plan, new/revised | New &or revised |
27750-9 | Medical social services treatment plan, new/revised | New &or revised |
29162-5 | Speech therapy treatment plan, new/revised | New &or revised |
52136-9 | None | New &or revised |
48299-2 | New coccine triggered leukotriene release [Mass/volume] by Leukocytes | New coccine leukotriene release |
45834-9 | None | New medications |
16262-8 | Newberyite crystals [Presence] in Stone by Infrared spectroscopy | Newberyite crystals |
42842-5 | None | Newborn behavior alteration |
32416-0 | None | Newborn complication |
54111-0 | None | Newborn hearing loss panel |
54107-8 | None | Newborn hearing screen |
54108-6 | None | Newborn hearing screen |
54109-4 | None | Newborn hearing screen |
54110-2 | None | Newborn hearing screen |
54106-0 | None | Newborn hearing screen method |
32417-8 | None | Newborn ICU admission diagnosis |
35085-0 | Newborn screening panel in Blood dot (filter paper) by American College of Medical Genetics (ACMG) | Newborn screening panel |
54089-8 | Newborn screening panel by American Health Information Community (AHIC) | Newborn screening panel |
49544-0 | Newborn screening recommended follow-up [interpretation] | Newborn screening recommended follow-up |
18671-8 | Alcohol-substance abuse rehabilitation treatment plan, next plan of treatment text (narrative) | Next plan of treatment |
52105-4 | Alcohol-substance abuse rehabilitation treatment plan, next plan of treatment (narrative) | Next plan of treatment |
30909-6 | Alcohol-substance abuse rehabilitation treatment plan, next planned treatment end date | Next planned treatment end date |
30908-8 | Alcohol-substance abuse rehabilitation treatment plan, next planned treatment start date | Next planned treatment start date |
21717-4 | NF1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | NF1 gene mutation analysis |
45331-6 | NF1 gene mutations found [Identifier] in Amniotic Fluid by Molecular genetics method Nominal | NF1 gene mutation analysis |
21718-2 | NF1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal | NF1 gene mutations tested for |
45332-4 | NF2 gene mutations found [Identifier] in Amniotic Fluid by Molecular genetics method Nominal | NF2 gene mutation analysis |
10836-5 | Niacin [Mass/volume] in Blood | Niacin |
18244-4 | Niacin [Mass/volume] in Serum or Plasma | Niacin |
2656-7 | Niacin [Mass/time] in 24 hour Urine | Niacin |
34342-6 | Niacin [Molecules/volume] in Serum or Plasma | Niacin |
51986-8 | Nicardipine [Presence] in Serum or Plasma | Nicardipine |
12779-5 | Nickel [Mass/time] in Urine | Nickel |
12780-3 | Nickel [Mass/volume] in Red Blood Cells | Nickel |
13649-9 | Nickel [Mass/volume] in Water | Nickel |
14099-6 | Nickel [Mass/volume] in Urine | Nickel |
18245-1 | Nickel [Mass/volume] in Unspecified specimen | Nickel |
25169-4 | Nickel [Molecules/volume] in Blood | Nickel |
25486-2 | Nickel [Molecules/volume] in Serum or Plasma | Nickel |
25487-0 | Nickel [Molecules/time] in 24 hour Urine | Nickel |
25961-4 | Nickel [Molecules/volume] in 24 hour Urine | Nickel |
29936-2 | Nickel [Mass/volume] in 24 hour Urine | Nickel |
30933-6 | Nickel [Mass/volume] in unspecified time Urine | Nickel |
34343-4 | Nickel [Molecules/volume] in Urine | Nickel |
47123-5 | Nickel [Molecules/mass] in Hair | Nickel |
50886-1 | Nickel [Molecules/mass] in Tissue | Nickel |
50887-9 | Nickel [Molecules/volume] in Red Blood Cells | Nickel |
51200-4 | Nickel [Mass/volume] in Body fluid | Nickel |
5700-0 | Nickel [Mass/volume] in Blood | Nickel |
5701-8 | Nickel [Mass/mass] in Hair | Nickel |
5702-6 | Nickel [Mass/volume] in Serum or Plasma | Nickel |
5703-4 | Nickel [Mass/time] in 24 hour Stool | Nickel |
5704-2 | Nickel [Presence] in Urine | Nickel |
5705-9 | Nickel [Mass/time] in 24 hour Urine | Nickel |
8207-3 | Nickel [Mass/volume] in Saliva | Nickel |
8208-1 | None | Nickel |
13472-6 | Nickel/Creatinine [Mass ratio] in Urine | Nickel/Creatinine |
25962-2 | Nickel/Creatinine [Molecular ratio] in 24 hour Urine | Nickel/Creatinine |
42001-8 | Nickel/Creatinine [Mass ratio] in 24 hour Urine | Nickel/Creatinine |
52926-3 | Nickel/Creatinine [Molecular ratio] in Urine | Nickel/Creatinine |
52462-9 | None | Nickname |
3851-3 | Nicomorphine [Mass/volume] in Urine | Nicomorphine |
4348-9 | Nicomorphine [Mass] of Dose | Nicomorphine |
6859-3 | Tobacco IgE Ab [Units/volume] in Serum | Nicotiana tabacum Ab.IgE |
16056-4 | Tobacco IgE Ab RAST class in Serum | Nicotiana tabacum Ab.IgE.RAST class |
7739-6 | Tobacco IgG Ab [Units/volume] in Serum | Nicotiana tabacum Ab.IgG |
7740-4 | Tobacco triggered histamine release [Units/volume] in Blood | Nicotiana tabacum basophil bound Ab |
7741-2 | None | Nicotiana tabacum cigarette Ab.IgE |
16055-6 | None | Nicotiana tabacum cigarette Ab.IgE.RAST class |
17362-5 | Nicotinamide [Presence] in Urine | Nicotinamide |
25488-8 | Nicotinamide [Molecules/volume] in Serum or Plasma | Nicotinamide |
27339-1 | Nicotinamide [Presence] in Blood | Nicotinamide |
3852-1 | Nicotinamide [Mass/volume] in Urine | Nicotinamide |
4349-7 | Nicotinamide [Mass] of Dose | Nicotinamide |
12294-5 | Nicotine [Presence] in Urine | Nicotine |
3853-9 | Nicotine [Mass/volume] in Serum or Plasma | Nicotine |
3854-7 | Nicotine [Mass/volume] in Urine | Nicotine |
40385-7 | Nicotine [Presence] in Meconium | Nicotine |
40386-5 | Nicotine [Presence] in Hair | Nicotine |
40387-3 | Nicotine [Presence] in Gastric fluid | Nicotine |
43195-7 | Nicotine [Presence] in Urine by Confirm method | Nicotine |
4350-5 | Nicotine [Mass] of Dose | Nicotine |
43830-9 | Nicotine [Presence] in Unspecified specimen | Nicotine |
43125-4 | Nicotine & Metabolites panel [Mass/volume] in Urine | Nicotine & Metabolites panel |
28555-1 | Nicotine+Cotinine [Presence] in Urine by Confirm method | Nicotine+Cotinine |
43218-7 | Nicotine+Cotinine [Presence] in Urine | Nicotine+Cotinine |
42192-5 | Nidus [Presence] in Stone | Nidus |
43594-1 | Nidus [Mass] in Stone | Nidus |
9386-4 | Nifedipine [Mass/volume] in Serum or Plasma | Nifedipine |
28392-9 | None | Night sweats |
7525-9 | Nigrospora oryzae IgE Ab [Units/volume] in Serum | Nigrospora oryzae Ab.IgE |
7526-7 | Nigrospora sphaerica IgE Ab [Units/volume] in Serum | Nigrospora sphaerica Ab.IgE |
15873-3 | Nigrospora sphaerica IgE Ab RAST class in Serum | Nigrospora sphaerica Ab.IgE.RAST class |
3855-4 | Nikethamide [Presence] in Urine | Nikethamide |
3856-2 | Nikethamide [Mass/volume] in Urine | Nikethamide |
3857-0 | Nikethamide [Mass/time] in 24 hour Urine | Nikethamide |
4351-3 | Nikethamide [Mass] of Dose | Nikethamide |
38907-2 | NIPA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | NIPA1 gene mutation analysis |
40428-5 | NIPBL gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Narrative | NIPBL gene mutation analysis |
41078-7 | NIPBL gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | NIPBL gene mutation analysis |
10826-6 | Nissel.microscopic observation [Identifier] in Tissue by Cresyl echt violet stain | Nissel.microscopic observation |
12538-5 | Nitrate [Mass/volume] in Blood | Nitrate |
21420-5 | Nitrate [Mass/volume] in Urine | Nitrate |
32030-9 | Nitrate [Presence] in Urine | Nitrate |
9480-5 | Nitrate [Mass/volume] in Water | Nitrate |
23762-8 | Nitrate+Nitrite [Mass/volume] in Unspecified specimen | Nitrate+Nitrite |
14849-4 | Nitrazepam [Molecules/volume] in Serum or Plasma | Nitrazepam |
14850-2 | Nitrazepam [Molecules/volume] in Urine | Nitrazepam |
17363-3 | Nitrazepam [Mass/volume] in Serum or Plasma by Confirm method | Nitrazepam |
19620-4 | Nitrazepam [Presence] in Urine by Screen method | Nitrazepam |
19621-2 | Nitrazepam [Presence] in Urine by Confirm method | Nitrazepam |
20552-6 | Nitrazepam [Mass/volume] in Urine by Confirm method | Nitrazepam |
3858-8 | Nitrazepam [Mass/volume] in Serum or Plasma | Nitrazepam |
3859-6 | Nitrazepam [Mass/volume] in Urine | Nitrazepam |
4352-1 | Nitrazepam [Mass] of Dose | Nitrazepam |
19622-0 | Nitrazepam cutoff [Mass/volume] in Urine for Screen method | Nitrazepam cutoff |
19623-8 | Nitrazepam cutoff [Mass/volume] in Urine for Confirm method | Nitrazepam cutoff |
13616-8 | Nitrite [Mass/volume] in Water | Nitrite |
18370-7 | Nitrite [Mass/volume] in Blood | Nitrite |
20407-3 | Nitrite [Mass/volume] in Urine by Test strip | Nitrite |
2657-5 | Nitrite [Mass/volume] in Urine | Nitrite |
32710-6 | Nitrite [Presence] in Urine | Nitrite |
50558-6 | Nitrite [Presence] in Urine by Automated test strip | Nitrite |
5802-4 | Nitrite [Presence] in Urine by Test strip | Nitrite |
38710-0 | Nitrobenzene [Mass/volume] in Air | Nitrobenzene |
32631-4 | Nitroblue Tetrazolium Test (NBT) [Presence] in Blood | Nitroblue tetrazolium test |
50609-7 | Nitroblue Tetrazolium Test (NBT) [Units/volume] in Blood | Nitroblue tetrazolium test |
18955-5 | Nitrofurantoin [Susceptibility] | Nitrofurantoin |
362-4 | Nitrofurantoin [Susceptibility] by Minimum lethal concentration (MLC) | Nitrofurantoin |
363-2 | Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC) | Nitrofurantoin |
364-0 | Nitrofurantoin [Susceptibility] by Disk diffusion (KB) | Nitrofurantoin |
365-7 | Nitrofurantoin [Susceptibility] by Serum bactericidal titer | Nitrofurantoin |
3860-4 | Nitrofurantoin [Mass/volume] in Serum or Plasma | Nitrofurantoin |
4353-9 | Nitrofurantoin [Mass] of Dose | Nitrofurantoin |
7036-7 | Nitrofurantoin [Susceptibility] by Gradient strip (E-test) | Nitrofurantoin |
16141-4 | Nitrogen [Mass/time] in 24 hour Stool | Nitrogen |
18246-9 | Nitrogen [Mass/volume] in Stool | Nitrogen |
18247-7 | Nitrogen [Mass/volume] in Dialysis fluid | Nitrogen |
2658-3 | Nitrogen [Mass/volume] in Exhaled gas | Nitrogen |
2659-1 | None | Nitrogen |
2660-9 | Nitrogen [Mass/time] in 24 hour Urine | Nitrogen |
2664-1 | None | Nitrogen |
2665-8 | Nitrogen [Mass/time] in Urine | Nitrogen |
40388-1 | Nitrogen [Molecules/time] in 24 hour Urine | Nitrogen |
47712-5 | Nitrogen [Presence] in Sweat | Nitrogen |
50888-7 | Nitrogen [Molecules/time] in Body fluid | Nitrogen |
50889-5 | Nitrogen [Molecules/volume] in 24 hour Urine | Nitrogen |
53142-6 | Nitrogen [Molecules/time] in 24 hour Stool | Nitrogen |
53554-2 | Nitrogen [Mass/volume] in Air | Nitrogen |
2661-7 | Nitrogen.nonprotein [Presence] in Blood | Nitrogen.nonprotein |
2662-5 | Nitrogen.nonprotein [Mass/volume] in Blood | Nitrogen.nonprotein |
2663-3 | Nitrogen.nonprotein [Mass/volume] in Serum or Plasma | Nitrogen.nonprotein |
53091-5 | Nitrogen.nonprotein [Molecules/volume] in Serum or Plasma | Nitrogen.nonprotein |
12404-0 | Nitroglycerin [Mass/volume] in Serum or Plasma | Nitroglycerin |
13016-1 | Nitrophenol [Units/volume] in Blood | Nitrophenol |
17364-1 | Nitrophenol [Presence] in Urine | Nitrophenol |
17365-8 | Nitroprusside [Mass/volume] in Serum or Plasma | Nitroprusside |
32548-0 | Nitroprusside reacting substances [Presence] in Urine | Nitroprusside reacting substances |
13892-5 | Nitrosonaphthol [Presence] in Urine | Nitrosonaphthol |
25608-1 | Nitroxoline [Susceptibility] | Nitroxoline |
25723-8 | Nitroxoline [Susceptibility] by Minimum inhibitory concentration (MIC) | Nitroxoline |
32382-4 | None | Nitroxoline |
17366-6 | Nizatidine [Mass/volume] in Serum or Plasma | Nizatidine |
47035-1 | NKI/C3 Ag [Presence] in Tissue by Immune stain | NKI-C3 Ag |
52834-9 | None | NMMDS nursing delivery unit or service panel |
52826-5 | None | NMMDS panel |
53410-7 | None | No change notification |
25060-5 | None | No charge |
45502-2 | None | No communication device |
46677-1 | None | No communicative limitations |
28162-6 | None | No energy to fight back |
46644-1 | None | No exertional limitations |
28528-8 | None | No good church experience |
46661-5 | None | No manipulative limitations |
45421-5 | None | No mental retardation and developmental disabilities |
45546-9 | None | No mode of transfer |
45540-2 | None | No modes of locomotion |
46652-4 | None | No postural limitations |
28532-0 | None | No purpose in life |
45583-2 | None | No unsettled relationships |
45514-7 | None | No visual limitations |
46668-0 | None | No visual limitations |
5263-9 | Nocardia sp Ab [Units/volume] in Serum | Nocardia sp Ab |
9569-5 | Nocardia sp IgG Ab [Units/volume] in Serum | Nocardia sp Ab.IgG |
14226-5 | Nocardia sp identified in Isolate by Organism specific culture | Nocardia sp identified |
43365-6 | Nocardia sp identified in Unspecified specimen by Organism specific culture | Nocardia sp identified |
46686-2 | None | Noise |
17367-4 | Nomifensine [Mass/volume] in Serum or Plasma | Nomifensine |
21942-8 | None | Non cancer directed surgery summary |
52072-6 | Non-Emergency Transportation | Non-emergency transportation attachment |
53246-5 | None | Non-medical services attachment |
53405-7 | None | Non-standardized allergenic label |
53207-7 | Nonanoylcarnitine (C9) [Molecules/volume] in Blood dot (filter paper) | Nonanoylcarnitine (C9) |
43680-8 | None | Nonclinical toxicology section |
28176-6 | None | Noncompliance |
32879-9 | None | Noncompliance with dental treatment |
28177-4 | None | Noncompliance with diagnostic test |
28178-2 | None | Noncompliance with dietary regimen |
28523-9 | None | Noncompliance with fluid volume |
28524-7 | None | Noncompliance with medication regimen |
28179-0 | None | Noncompliance with safety precautions |
28180-8 | None | Noncompliance with therapeutic regimen |
45445-4 | None | None of the listed additional ADL patterns |
45435-5 | None | None of the listed cycle of daily events |
45679-8 | None | None of the listed diseases or conditions |
45439-7 | None | None of the listed eating patterns |
45451-2 | None | None of the listed involvement patterns |
45417-3 | None | None of the listed prior residential settings |
35007-4 | Nonhematic cells [#/volume] in Cerebral spinal fluid | Nonhematic cells |
35008-2 | Nonhematic cells [#/volume] in Body fluid | Nonhematic cells |
13525-1 | Nonhematic cells/100 leukocytes in Cerebral spinal fluid by Manual count | Nonhematic cells/100 leukocytes |
13526-9 | Nonhematic cells/100 leukocytes in Body fluid by Manual count | Nonhematic cells/100 leukocytes |
30456-8 | Nonhematic cells/100 leukocytes in Cerebral spinal fluid | Nonhematic cells/100 leukocytes |
30457-6 | Nonhematic cells/100 leukocytes in Body fluid | Nonhematic cells/100 leukocytes |
34078-6 | None | Nonteratogenic effects section |
54003-9 | NOR-90 Ab [Presence] in Serum by Immunofluorescence | NOR-90 Ab |
54004-7 | NOR-90 Ab [Titer] in Serum by Immunofluorescence | NOR-90 Ab |
10532-0 | None | Noramiodarone |
12709-2 | Norastemizole [Mass/volume] in Serum or Plasma | Norastemizole |
49751-1 | Norbuprenorphine [Mass/volume] in Urine by Confirm method | Norbuprenorphine |
49753-7 | Norbuprenorphine [Mass/volume] in Urine | Norbuprenorphine |
53880-1 | Norbuprenorphine [Mass/volume] in Serum or Plasma by Confirm method | Norbuprenorphine |
53881-9 | Norbuprenorphine [Mass/volume] in Serum or Plasma | Norbuprenorphine |
12373-7 | None | Norchlordiazepoxide |
13569-9 | Norchlordiazepoxide [Presence] in Serum or Plasma | Norchlordiazepoxide |
27036-3 | Norchlordiazepoxide [Mass/volume] in Urine | Norchlordiazepoxide |
33301-3 | Norchlordiazepoxide [Presence] in Urine by Screen method | Norchlordiazepoxide |
9776-6 | Norchlordiazepoxide [Mass/volume] in Serum or Plasma | Norchlordiazepoxide |
26040-6 | Norcitalopram [Molecules/volume] in Serum or Plasma | Norcitalopram |
35106-4 | Norcitalopram [Mass/volume] in Serum or Plasma | Norcitalopram |
14693-6 | Norclobazam [Molecules/volume] in Serum or Plasma | Norclobazam |
35107-2 | Norclobazam [Mass/volume] in Serum or Plasma | Norclobazam |
13570-7 | Norclomipramine [Presence] in Serum or Plasma | Norclomipramine |
14694-4 | Norclomipramine [Molecules/volume] in Serum or Plasma | Norclomipramine |
18470-5 | Norclomipramine [Mass/volume] in Urine | Norclomipramine |
3536-0 | Norclomipramine [Mass/volume] in Serum or Plasma | Norclomipramine |
35621-2 | Norclomipramine [Mass/volume] in Serum or Plasma by Screen method | Norclomipramine |
10992-6 | Norclozapine [Mass/volume] in Serum or Plasma | Norclozapine |
12376-0 | None | Norclozapine |
13571-5 | Norclozapine [Presence] in Serum or Plasma | Norclozapine |
14851-0 | Norclozapine [Molecules/volume] in Serum or Plasma | Norclozapine |
50890-3 | Norclozapine [Molecules/volume] in Urine | Norclozapine |
49829-5 | Norcodeine [Mass/volume] in Urine | Norcodeine |
49830-3 | Norcodeine [Mass/volume] in Serum or Plasma | Norcodeine |
13572-3 | Nordiazepam [Presence] in Serum or Plasma | Nordiazepam |
15372-6 | Nordiazepam [Mass/volume] in Urine | Nordiazepam |
16202-4 | Nordiazepam [Presence] in Urine by Confirm method | Nordiazepam |
16228-9 | Nordiazepam [Mass/volume] in Urine by Confirm method | Nordiazepam |
16743-7 | None | Nordiazepam |
16744-5 | None | Nordiazepam |
18248-5 | Nordiazepam [Mass/volume] in Stool | Nordiazepam |
19624-6 | Nordiazepam [Presence] in Urine by Screen method | Nordiazepam |
26021-6 | Nordiazepam [Molecules/volume] in Serum or Plasma | Nordiazepam |
26816-9 | Nordiazepam [Mass/volume] in Vitreous fluid | Nordiazepam |
26840-9 | Nordiazepam [Mass/mass] in Hair | Nordiazepam |
26891-2 | Nordiazepam [Mass/mass] in Meconium | Nordiazepam |
27239-3 | Nordiazepam [Mass/mass] in Stool | Nordiazepam |
29385-2 | Nordiazepam [Mass/volume] in Gastric fluid | Nordiazepam |
3537-8 | Nordiazepam [Mass/volume] in Serum or Plasma | Nordiazepam |
35622-0 | Nordiazepam [Mass/volume] in Serum or Plasma by Screen method | Nordiazepam |
3861-2 | Nordiazepam [Presence] in Urine | Nordiazepam |
4213-5 | Nordiazepam [Mass] of Dose | Nordiazepam |
4354-7 | None | Nordiazepam |
48959-1 | Nordiazepam [Mass/volume] in Unspecified specimen | Nordiazepam |
19626-1 | Nordiazepam cutoff [Mass/volume] in Urine for Screen method | Nordiazepam cutoff |
19627-9 | Nordiazepam cutoff [Mass/volume] in Urine for Confirm method | Nordiazepam cutoff |
35114-8 | Nordothiepin [Mass/volume] in Serum or Plasma | Nordothiepin |
12386-9 | Nordoxepin [Mass/volume] in Urine | Nordoxepin |
13573-1 | Nordoxepin [Presence] in Serum or Plasma | Nordoxepin |
14695-1 | Nordoxepin [Molecules/volume] in Serum or Plasma | Nordoxepin |
29411-6 | Nordoxepin [Mass/volume] in Gastric fluid | Nordoxepin |
35623-8 | Nordoxepin [Mass/volume] in Serum or Plasma by Screen method | Nordoxepin |
3862-0 | Nordoxepin [Mass/volume] in Serum or Plasma | Nordoxepin |
4210-1 | Nordoxepin [Mass] of Dose | Nordoxepin |
4355-4 | None | Nordoxepin |
14852-8 | Norepinephrine [Molecules/volume] in Plasma | Norepinephrine |
14853-6 | Norepinephrine [Molecules/volume] in Urine | Norepinephrine |
14854-4 | Norepinephrine [Molecules/time] in 24 hour Urine | Norepinephrine |
25963-0 | Norepinephrine [Molecules/volume] in 24 hour Urine | Norepinephrine |
2666-6 | Norepinephrine [Mass/volume] in Plasma | Norepinephrine |
2667-4 | Norepinephrine [Mass/volume] in Urine | Norepinephrine |
2668-2 | Norepinephrine [Mass/time] in 24 hour Urine | Norepinephrine |
27221-1 | Norepinephrine [Mass/volume] in 24 hour Urine | Norepinephrine |
4356-2 | Norepinephrine [Mass] of Dose | Norepinephrine |
13782-8 | Norepinephrine/Creatinine [Mass ratio] in Urine | Norepinephrine/Creatinine |
24523-3 | Norepinephrine/Creatinine [Molecular ratio] in Urine | Norepinephrine/Creatinine |
27977-8 | Norepinephrine/Creatinine [Molecular ratio] in 24 hour Urine | Norepinephrine/Creatinine |
32549-8 | Norepinephrine/Creatinine [Molecular ratio] in unspecified time Urine | Norepinephrine/Creatinine |
44341-6 | Norepinephrine/Creatinine [Mass ratio] in 24 hour Urine | Norepinephrine/Creatinine |
1602-2 | Norepinephrine [Mass/volume] in Plasma --10 minutes post standing | Norepinephrine^10M post standing |
47155-7 | Norepinephrine [Molecules/volume] in Plasma --10 minutes post standing | Norepinephrine^10M post standing |
1603-0 | Norepinephrine [Mass/volume] in Plasma --1 hour post 300 ug clonidine PO | Norepinephrine^1H post 300 ug clonidine PO |
47156-5 | Norepinephrine [Molecules/volume] in Plasma --1 hour post 300 ug clonidine PO | Norepinephrine^1H post 300 ug clonidine PO |
12525-2 | Norepinephrine [Mass/volume] in Plasma --1 hour post XXX challenge | Norepinephrine^1H post XXX challenge |
47157-3 | Norepinephrine [Molecules/volume] in Plasma --1 hour post XXX challenge | Norepinephrine^1H post XXX challenge |
1604-8 | Norepinephrine [Mass/volume] in Plasma --2 hours post 300 ug clonidine PO | Norepinephrine^2H post 300 ug clonidine PO |
47158-1 | Norepinephrine [Molecules/volume] in Plasma --2 hours post 300 ug clonidine PO | Norepinephrine^2H post 300 ug clonidine PO |
12526-0 | Norepinephrine [Mass/volume] in Plasma --2 hours post XXX challenge | Norepinephrine^2H post XXX challenge |
47159-9 | Norepinephrine [Molecules/volume] in Plasma --2 hours post XXX challenge | Norepinephrine^2H post XXX challenge |
13426-2 | Norepinephrine [Mass/volume] in Plasma --2nd specimen post XXX challenge | Norepinephrine^2nd specimen post XXX challenge |
17369-0 | Norepinephrine [Mass/volume] in Urine --2nd specimen post XXX challenge | Norepinephrine^2nd specimen post XXX challenge |
47160-7 | Norepinephrine [Molecules/volume] in Plasma --2nd specimen post XXX challenge | Norepinephrine^2nd specimen post XXX challenge |
47161-5 | Norepinephrine [Molecules/volume] in Urine --2nd specimen post XXX challenge | Norepinephrine^2nd specimen post XXX challenge |
1605-5 | Norepinephrine [Mass/volume] in Plasma --3 hours post 300 ug clonidine PO | Norepinephrine^3H post 300 ug clonidine PO |
47162-3 | Norepinephrine [Molecules/volume] in Plasma --3 hours post 300 ug clonidine PO | Norepinephrine^3H post 300 ug clonidine PO |
12527-8 | Norepinephrine [Mass/volume] in Plasma --3 hours post XXX challenge | Norepinephrine^3H post XXX challenge |
47163-1 | Norepinephrine [Molecules/volume] in Plasma --3 hours post XXX challenge | Norepinephrine^3H post XXX challenge |
13427-0 | Norepinephrine [Mass/volume] in Plasma --3rd specimen post XXX challenge | Norepinephrine^3rd specimen post XXX challenge |
17370-8 | Norepinephrine [Mass/volume] in Urine --3rd specimen post XXX challenge | Norepinephrine^3rd specimen post XXX challenge |
47164-9 | Norepinephrine [Molecules/volume] in Plasma --3rd specimen post XXX challenge | Norepinephrine^3rd specimen post XXX challenge |
47165-6 | Norepinephrine [Molecules/volume] in Urine --3rd specimen post XXX challenge | Norepinephrine^3rd specimen post XXX challenge |
12528-6 | Norepinephrine [Mass/volume] in Plasma --4 hours post XXX challenge | Norepinephrine^4H post XXX challenge |
47166-4 | Norepinephrine [Molecules/volume] in Plasma --4 hours post XXX challenge | Norepinephrine^4H post XXX challenge |
13428-8 | Norepinephrine [Mass/volume] in Plasma --4th specimen post XXX challenge | Norepinephrine^4th specimen post XXX challenge |
17371-6 | Norepinephrine [Mass/volume] in Urine --4th specimen post XXX challenge | Norepinephrine^4th specimen post XXX challenge |
47167-2 | Norepinephrine [Molecules/volume] in Plasma --4th specimen post XXX challenge | Norepinephrine^4th specimen post XXX challenge |
47168-0 | Norepinephrine [Molecules/volume] in Urine --4th specimen post XXX challenge | Norepinephrine^4th specimen post XXX challenge |
13429-6 | Norepinephrine [Mass/volume] in Plasma --5th specimen post XXX challenge | Norepinephrine^5th specimen post XXX challenge |
17372-4 | Norepinephrine [Mass/volume] in Urine --5th specimen post XXX challenge | Norepinephrine^5th specimen post XXX challenge |
47169-8 | Norepinephrine [Molecules/volume] in Plasma --5th specimen post XXX challenge | Norepinephrine^5th specimen post XXX challenge |
47170-6 | Norepinephrine [Molecules/volume] in Urine --5th specimen post XXX challenge | Norepinephrine^5th specimen post XXX challenge |
13430-4 | Norepinephrine [Mass/volume] in Plasma --6th specimen post XXX challenge | Norepinephrine^6th specimen post XXX challenge |
17373-2 | Norepinephrine [Mass/volume] in Urine --6th specimen post XXX challenge | Norepinephrine^6th specimen post XXX challenge |
47171-4 | Norepinephrine [Molecules/volume] in Plasma --6th specimen post XXX challenge | Norepinephrine^6th specimen post XXX challenge |
47172-2 | Norepinephrine [Molecules/volume] in Urine --6th specimen post XXX challenge | Norepinephrine^6th specimen post XXX challenge |
13431-2 | Norepinephrine [Mass/volume] in Plasma --7th specimen post XXX challenge | Norepinephrine^7th specimen post XXX challenge |
17374-0 | Norepinephrine [Mass/volume] in Urine --7th specimen post XXX challenge | Norepinephrine^7th specimen post XXX challenge |
47174-8 | Norepinephrine [Molecules/volume] in Urine --7th specimen post XXX challenge | Norepinephrine^7th specimen post XXX challenge |
49009-4 | Norepinephrine [Molecules/volume] in Plasma --7th specimen post XXX challenge | Norepinephrine^7th specimen post XXX challenge |
1606-3 | Norepinephrine [Mass/volume] in Plasma --pre 300 ug clonidine PO | Norepinephrine^pre 300 ug clonidine PO |
47175-5 | Norepinephrine [Molecules/volume] in Plasma --pre 300 ug clonidine PO | Norepinephrine^pre 300 ug clonidine PO |
51429-9 | Norepinephrine [Molecules/volume] in Serum or Plasma --pre/post XXX challenge | Norepinephrine^pre/post XXX challenge |
17368-2 | Norepinephrine [Mass/volume] in Plasma --standing | Norepinephrine^standing |
33843-4 | Norepinephrine [Molecules/volume] in Plasma --standing | Norepinephrine^standing |
1601-4 | Norepinephrine [Mass/volume] in Plasma --supine | Norepinephrine^supine |
33844-2 | Norepinephrine [Molecules/volume] in Plasma --supine | Norepinephrine^supine |
3863-8 | Norethandrolone [Presence] in Urine | Norethandrolone |
3864-6 | Norethandrolone [Mass/volume] in Urine | Norethandrolone |
3865-3 | Norethandrolone [Mass/time] in 24 hour Urine | Norethandrolone |
4357-0 | Norethandrolone [Mass] of Dose | Norethandrolone |
13907-1 | Norethindrone [Mass/volume] in Serum or Plasma | Norethindrone |
49756-0 | Norethindrone [Mass/volume] in Urine | Norethindrone |
3866-1 | Norfenefrine [Mass/volume] in Urine | Norfenefrine |
4358-8 | Norfenefrine [Mass] of Dose | Norfenefrine |
12431-3 | Norfenfluramine [Mass/volume] in Serum or Plasma | Norfenfluramine |
11074-2 | Norfentanyl [Mass/volume] in Serum or Plasma | Norfentanyl |
11075-9 | Norfentanyl [Mass/volume] in Urine | Norfentanyl |
43199-9 | Norfentanyl [Presence] in Urine | Norfentanyl |
43200-5 | Norfentanyl [Presence] in Urine by Confirm method | Norfentanyl |
18956-3 | Norfloxacin [Susceptibility] | Norfloxacin |
366-5 | Norfloxacin [Susceptibility] by Minimum lethal concentration (MLC) | Norfloxacin |
367-3 | Norfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Norfloxacin |
368-1 | Norfloxacin [Susceptibility] by Disk diffusion (KB) | Norfloxacin |
369-9 | Norfloxacin [Susceptibility] by Serum bactericidal titer | Norfloxacin |
3867-9 | Norfloxacin [Mass/volume] in Serum or Plasma | Norfloxacin |
41504-2 | Norfloxacin [Susceptibility] by Method for Slow-growing mycobacteria | Norfloxacin |
4359-6 | Norfloxacin [Mass] of Dose | Norfloxacin |
7037-5 | Norfloxacin [Susceptibility] by Gradient strip (E-test) | Norfloxacin |
17375-7 | Norflunitrazepam [Mass/volume] in Blood | Norflunitrazepam |
26039-8 | Norflunitrazepam [Molecules/volume] in Serum or Plasma | Norflunitrazepam |
27083-5 | Norflunitrazepam [Mass/volume] in Urine | Norflunitrazepam |
32650-4 | Norflunitrazepam [Mass/volume] in Serum or Plasma | Norflunitrazepam |
12445-3 | Norfluoxetine [Mass/volume] in Urine | Norfluoxetine |
13574-9 | Norfluoxetine [Presence] in Serum or Plasma | Norfluoxetine |
14855-1 | Norfluoxetine [Molecules/volume] in Serum or Plasma | Norfluoxetine |
19628-7 | Norfluoxetine [Presence] in Urine by Screen method | Norfluoxetine |
19629-5 | Norfluoxetine [Presence] in Urine by Confirm method | Norfluoxetine |
20553-4 | Norfluoxetine [Mass/volume] in Urine by Confirm method | Norfluoxetine |
35624-6 | Norfluoxetine [Mass/volume] in Serum or Plasma by Screen method | Norfluoxetine |
3868-7 | Norfluoxetine [Mass/volume] in Serum or Plasma | Norfluoxetine |
19630-3 | Norfluoxetine cutoff [Mass/volume] in Urine for Screen method | Norfluoxetine cutoff |
19631-1 | Norfluoxetine cutoff [Mass/volume] in Urine for Confirm method | Norfluoxetine cutoff |
18322-8 | Norketamine [Mass/volume] in Urine | Norketamine |
21421-3 | Norketamine [Mass/volume] in Serum or Plasma | Norketamine |
13575-6 | Normaprotiline [Presence] in Serum or Plasma | Normaprotiline |
35108-0 | Normaprotiline [Mass/volume] in Serum or Plasma | Normaprotiline |
10544-5 | Normeperidine [Presence] in Serum or Plasma | Normeperidine |
10996-7 | Normeperidine [Mass/volume] in Serum or Plasma | Normeperidine |
27920-8 | Normeperidine [Presence] in Urine | Normeperidine |
35625-3 | Normeperidine [Mass/volume] in Serum or Plasma by Screen method | Normeperidine |
3869-5 | Normeperidine [Mass/volume] in Urine | Normeperidine |
10545-2 | Normephenytoin [Mass/volume] in Serum or Plasma | Normephenytoin |
26041-4 | Normephenytoin [Molecules/volume] in Serum or Plasma | Normephenytoin |
15083-9 | Normetanephrine [Molecules/time] in 24 hour Urine | Normetanephrine |
21422-1 | Normetanephrine [Mass/volume] in 24 hour Urine | Normetanephrine |
25489-6 | Normetanephrine [Molecules/volume] in Serum or Plasma | Normetanephrine |
25964-8 | Normetanephrine [Molecules/volume] in 24 hour Urine | Normetanephrine |
2669-0 | Normetanephrine [Mass/volume] in Serum or Plasma | Normetanephrine |
2670-8 | Normetanephrine [Mass/volume] in Urine | Normetanephrine |
2671-6 | Normetanephrine [Mass/time] in 24 hour Urine | Normetanephrine |
34347-5 | Normetanephrine [Molecules/volume] in Urine | Normetanephrine |
4360-4 | Normetanephrine [Mass] of Dose | Normetanephrine |
40851-8 | Normetanephrine Free [Molecules/volume] in Serum or Plasma | Normetanephrine.free |
13783-6 | Normetanephrine/Creatinine [Mass ratio] in Urine | Normetanephrine/Creatinine |
34348-3 | Normetanephrine/Creatinine [Molecular ratio] in Urine | Normetanephrine/Creatinine |
44342-4 | Normetanephrine/Creatinine [Mass ratio] in 24 hour Urine | Normetanephrine/Creatinine |
44924-9 | Normetanephrine/Creatinine [Molecular ratio] in 24 hour Urine | Normetanephrine/Creatinine |
10546-0 | Normethsuximide [Mass/volume] in Serum or Plasma | Normethsuximide |
10890-2 | None | Normethsuximide |
39483-3 | Normethsuximide [Molecules/volume] in Serum or Plasma | Normethsuximide |
34414-3 | Normianserin [Mass/volume] in Serum or Plasma | Normianserin |
34415-0 | Normirtazapine [Mass/volume] in Serum or Plasma | Normirtazapine |
715-3 | Normoblasts [#/volume] in Blood | Normoblasts |
11104-7 | Normoblasts Basophilic/100 cells in Bone marrow by Microscopy | Normoblasts.basophilic/100 cells |
11116-1 | Normoblasts Orthochromic/100 cells in Bone marrow by Microscopy | Normoblasts.orthochromic/100 cells |
51717-7 | Normoblasts Orthochromic/100 cells in Blood by Microscopy | Normoblasts.orthochromic/100 cells |
11119-5 | Normoblasts Polychromatophilic/100 cells in Bone marrow by Microscopy | Normoblasts.polychromatophilic/100 cells |
51718-5 | Normoblasts Polychromatophilic/100 cells in Blood by Microscopy | Normoblasts.polychromatophilic/100 cells |
33957-2 | Normoblasts/100 blasts in Blood | Normoblasts/100 blasts |
51579-1 | Normoblasts/100 cells in Bone marrow by Microscopy | Normoblasts/100 cells |
33990-3 | Normoblasts/100 leukocytes [Ratio] in Blood | Normoblasts/100 leukocytes |
33364-1 | Normochromic [Presence] in Blood by Light microscopy | Normochromic |
33363-3 | Normocytic [Presence] in Blood by Light microscopy | Normocytic |
7794-1 | Normocytic/Normochromic polychromasia [Presence] in Blood by Light microscopy | Normocytic/Normochromic polychromasia |
49831-1 | Normorphine [Mass/volume] in Urine | Normorphine |
33917-6 | Nornicotine [Mass/volume] in Urine | Nornicotine |
49117-5 | Norovirus Ag [Presence] in Stool | Norovirus Ag |
10983-5 | Norparamethadione [Mass/volume] in Serum or Plasma | Norparamethadione |
27402-7 | Norparamethadione [Mass/volume] in Urine | Norparamethadione |
10341-6 | Norpropoxyphene [Mass/volume] in Serum or Plasma | Norpropoxyphene |
17376-5 | Norpropoxyphene [Presence] in Urine by Confirm method | Norpropoxyphene |
17377-3 | Norpropoxyphene [Mass/volume] in Urine by Confirm method | Norpropoxyphene |
19632-9 | Norpropoxyphene [Presence] in Urine by Screen method | Norpropoxyphene |
19635-2 | Norpropoxyphene [Mass/volume] in Urine | Norpropoxyphene |
27029-8 | Norpropoxyphene [Mass/mass] in Meconium | Norpropoxyphene |
27041-3 | Norpropoxyphene [Mass/mass] in Stool | Norpropoxyphene |
27211-2 | Norpropoxyphene [Mass/mass] in Hair | Norpropoxyphene |
29387-8 | Norpropoxyphene [Mass/volume] in Gastric fluid | Norpropoxyphene |
35626-1 | Norpropoxyphene [Mass/volume] in Serum or Plasma by Screen method | Norpropoxyphene |
3870-3 | Norpropoxyphene [Presence] in Serum or Plasma | Norpropoxyphene |
3871-1 | Norpropoxyphene [Presence] in Urine | Norpropoxyphene |
48960-9 | Norpropoxyphene [Mass/volume] in Unspecified specimen | Norpropoxyphene |
19636-0 | Norpropoxyphene cutoff [Mass/volume] in Urine for Screen method | Norpropoxyphene cutoff |
19637-8 | Norpropoxyphene cutoff [Mass/volume] in Urine for Confirm method | Norpropoxyphene cutoff |
13557-4 | Norsertraline [Presence] in Serum or Plasma | Norsertraline |
25724-6 | None | Norsertraline |
6897-3 | Norsertraline [Mass/volume] in Serum or Plasma | Norsertraline |
43239-3 | Norsildenafil [Mass/volume] in Serum or Plasma | Norsildenafil |
49083-9 | None | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) panel |
49143-1 | None | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) Pathology Laboratory Electronic Reporting panel |
12438-8 | Nortramadol [Mass/volume] in Serum or Plasma | Nortramadol |
18338-4 | Nortramadol [Mass/volume] in Urine | Nortramadol |
18339-2 | Nortramadol [Presence] in Serum or Plasma by Confirm method | Nortramadol |
18340-0 | Nortramadol [Mass/volume] in Serum or Plasma by Confirm method | Nortramadol |
12444-6 | Nortrimipramine [Mass/volume] in Urine | Nortrimipramine |
16746-0 | Nortrimipramine [Mass/volume] in Serum or Plasma | Nortrimipramine |
25394-8 | Nortrimipramine [Molecules/volume] in Serum or Plasma | Nortrimipramine |
49691-9 | Nortrimipramine [Presence] in Serum or Plasma | Nortrimipramine |
14856-9 | Nortriptyline [Molecules/volume] in Serum or Plasma | Nortriptyline |
29407-4 | Nortriptyline [Mass/volume] in Gastric fluid | Nortriptyline |
35627-9 | Nortriptyline [Mass/volume] in Serum or Plasma by Screen method | Nortriptyline |
3872-9 | Nortriptyline [Mass/volume] in Serum or Plasma | Nortriptyline |
3873-7 | Nortriptyline [Presence] in Serum or Plasma | Nortriptyline |
3874-5 | Nortriptyline [Presence] in Urine | Nortriptyline |
3875-2 | Nortriptyline [Mass/volume] in Urine | Nortriptyline |
40389-9 | Nortriptyline [Presence] in Gastric fluid | Nortriptyline |
4361-2 | Nortriptyline [Mass] of Dose | Nortriptyline |
45301-9 | Nortriptyline [Molecules/volume] in Urine | Nortriptyline |
3876-0 | Nortriptyline [Mass/volume] in Serum or Plasma --trough >12 hours post dose | Nortriptyline^trough >12h post dose |
48362-8 | Norvenlafaxine [Molecules/volume] in Serum or Plasma | Norvenlafaxine |
53882-7 | Norvenlafaxine [Mass/volume] in Urine | Norvenlafaxine |
9628-9 | Norvenlafaxine [Mass/volume] in Serum or Plasma | Norvenlafaxine |
35628-7 | Norverapamil [Presence] in Serum or Plasma by Screen method | Norverapamil |
6903-9 | Norverapamil [Mass/volume] in Serum or Plasma | Norverapamil |
10696-3 | Norwalk virus [Identifier] in Stool by Electron microscopy | Norwalk virus |
7973-1 | Norwalk virus [Presence] in Stool by Electron microscopy | Norwalk virus |
40863-3 | Norwalk virus 1 Ag [Identifier] in Stool | Norwalk virus 1 Ag |
41035-7 | Norwalk virus RNA [Presence] in Unspecified specimen by DNA probe | Norwalk virus RNA |
7974-9 | Norwalk virus RNA [Presence] in Stool by Probe & target amplification method | Norwalk virus RNA |
1268-2 | Other Ab [Presence] in Serum or Plasma from Blood product unit | NOS Ab |
1269-0 | Other Ab [Presence] in Serum or Plasma from donor | NOS Ab |
28163-4 | None | Not enjoying life |
34492-9 | NOTCH3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Narrative | NOTCH3 gene mutation analysis |
41077-9 | NOTCH3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | NOTCH3 gene mutation analysis |
34903-5 | None | Note |
34906-8 | None | Note |
46210-1 | Case manager note | Note |
46215-0 | Wound care management note | Note |
51855-5 | None | Note |
11536-0 | None | Notes |
52066-8 | NODMAR (Notice of Discharge Medicare Appeal Rights) Form | Notice of Discharge Medicare Appeal Rights Form attachment |
53244-0 | None | Notice of privacy practices receipt attachment |
44646-8 | None | Nottingham mitotic count.25x obj |
44647-6 | None | Nottingham mitotic count.40x obj |
17378-1 | Novobiocin [Mass/volume] in Serum or Plasma | Novobiocin |
18957-1 | Novobiocin [Susceptibility] | Novobiocin |
370-7 | Novobiocin [Susceptibility] by Minimum lethal concentration (MLC) | Novobiocin |
371-5 | Novobiocin [Susceptibility] by Minimum inhibitory concentration (MIC) | Novobiocin |
372-3 | Novobiocin [Susceptibility] by Disk diffusion (KB) | Novobiocin |
373-1 | Novobiocin [Susceptibility] by Serum bactericidal titer | Novobiocin |
41706-3 | Novobiocin [Susceptibility] by Gradient strip (E-test) | Novobiocin |
49864-2 | Novocaine IgE Ab [Units/volume] in Serum | Novocaine Ab.IgE |
34505-8 | NPDC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Narrative | NPDC gene mutation analysis |
41076-1 | NPDC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | NPDC gene mutation analysis |
34512-4 | NPHS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Narrative | NPHS1 gene mutation analysis |
34513-2 | NPHS1 gene mutations found [Identifier] in Body fluid by Molecular genetics method Narrative | NPHS1 gene mutation analysis |
41074-6 | NPHS1 gene mutations found [Identifier] in Body fluid by Molecular genetics method Nominal | NPHS1 gene mutation analysis |
41075-3 | NPHS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | NPHS1 gene mutation analysis |
34739-3 | NR0B1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Narrative | NR0B1 gene mutation analysis |
41073-8 | NR0B1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | NR0B1 gene mutation analysis |
21719-0 | NRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | NRAS gene mutation analysis |
53621-9 | NRAS gene mutations found [Identifier] in Bone marrow by Molecular genetics method Nominal | NRAS gene mutation analysis |
21720-8 | NRAS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal | NRAS gene mutations tested for |
44621-1 | None | Nregional lymph nodes identified |
35645-1 | NSD1 gene deletion [Presence] in Blood or Tissue by Molecular genetics method | NSD1 gene deletion |
47967-5 | NSD1 gene mutations found [Presence] in Blood or Tissue by Molecular genetics method | NSD1 gene mutation analysis |
13066-6 | Nuclear Ab [Units/volume] in Body fluid by Immunofluorescence | Nuclear Ab |
13111-0 | None | Nuclear Ab |
13112-8 | None | Nuclear Ab |
14607-6 | Nuclear Ab [Presence] in Body fluid | Nuclear Ab |
14608-4 | Nuclear Ab [Presence] in Pleural fluid | Nuclear Ab |
14609-2 | Nuclear Ab [Presence] in Peritoneal fluid | Nuclear Ab |
14610-0 | Nuclear Ab [Presence] in Synovial fluid | Nuclear Ab |
14612-6 | Nuclear Ab [Titer] in Pericardial fluid | Nuclear Ab |
14613-4 | Nuclear Ab [Titer] in Body fluid | Nuclear Ab |
14614-2 | Nuclear Ab [Titer] in Pleural fluid | Nuclear Ab |
14615-9 | Nuclear Ab [Titer] in Peritoneal fluid | Nuclear Ab |
14616-7 | Nuclear Ab [Titer] in Synovial fluid | Nuclear Ab |
16392-3 | Nuclear Ab [Presence] in Serum by Rodent substrate | Nuclear Ab |
16393-1 | Nuclear Ab [Units/volume] in Serum by Rodent substrate | Nuclear Ab |
16394-9 | Nuclear Ab [Presence] in Body fluid by Immunofluorescence | Nuclear Ab |
21423-9 | Nuclear Ab [Titer] in Serum by Immunofluorescence (IF) rat liver | Nuclear Ab |
27200-5 | Nuclear Ab [Units/volume] in Serum | Nuclear Ab |
29953-7 | Nuclear Ab [Titer] in Serum | Nuclear Ab |
31540-8 | Nuclear Ab [Units/volume] in Body fluid | Nuclear Ab |
31541-6 | Nuclear Ab [Units/volume] in Pericardial fluid | Nuclear Ab |
31542-4 | Nuclear Ab [Units/volume] in Pleural fluid | Nuclear Ab |
31543-2 | Nuclear Ab [Units/volume] in Peritoneal fluid | Nuclear Ab |
31544-0 | Nuclear Ab [Units/volume] in Synovial fluid | Nuclear Ab |
33253-6 | Nuclear Ab [Titer] in Serum by Hep2 substrate | Nuclear Ab |
40655-3 | Nuclear Ab [Titer] in Serum by Immunoassay | Nuclear Ab |
42254-3 | Nuclear Ab [Presence] in Serum by Immunofluorescence | Nuclear Ab |
44751-6 | Nuclear Ab [Presence] in Serum by Immunofluorescence (IF) rat kidney | Nuclear Ab |
44752-4 | Nuclear Ab [Units/volume] in Serum by Immunofluorescence (IF) rat kidney | Nuclear Ab |
47383-5 | Nuclear Ab [Presence] in Serum by Immunoassay | Nuclear Ab |
5047-6 | Nuclear Ab [Units/volume] in Serum by Immunoassay | Nuclear Ab |
5048-4 | Nuclear Ab [Titer] in Serum by Immunofluorescence | Nuclear Ab |
6822-1 | Nuclear Ab [Titer] in Synovial fluid by Indirect fluorescence antibody (IFA) | Nuclear Ab |
8061-4 | Nuclear Ab [Presence] in Serum | Nuclear Ab |
9423-5 | Nuclear Ab [Units/volume] in Serum by Immunofluorescence | Nuclear Ab |
13067-4 | Nuclear Ab pattern [interpretation] in Body fluid by Immunofluorescence | Nuclear Ab pattern |
13068-2 | Nuclear Ab pattern [interpretation] in Serum by Immunofluorescence | Nuclear Ab pattern |
14611-8 | Nuclear Ab pattern [interpretation] in Serum | Nuclear Ab pattern |
49309-8 | Nuclear Ab pattern [interpretation] in Body fluid by Immunofluorescence Narrative | Nuclear Ab pattern |
49310-6 | Nuclear Ab pattern [interpretation] in Serum Narrative | Nuclear Ab pattern |
49311-4 | Nuclear Ab pattern [interpretation] in Serum by Immunofluorescence Narrative | Nuclear Ab pattern |
53987-4 | Nuclear Ab pattern.atypic speckled [Titer] in Serum by Immunofluorescence | Nuclear Ab pattern.atypic speckled |
53988-2 | Nuclear Ab pattern.atypic speckled [Presence] in Serum by Immunofluorescence | Nuclear Ab pattern.atypic speckled |
53993-2 | Nuclear Ab pattern.centrosomal [Titer] in Serum by Immunofluorescence | Nuclear Ab pattern.centrosomal |
53994-0 | Nuclear Ab pattern.centrosomal [Presence] in Serum by Immunofluorescence | Nuclear Ab pattern.centrosomal |
53989-0 | Nuclear Ab pattern.chromosomal [Titer] in Serum by Immunofluorescence | Nuclear Ab pattern.chromosomal |
53990-8 | Nuclear Ab pattern.chromosomal [Presence] in Serum by Immunofluorescence | Nuclear Ab pattern.chromosomal |
53985-8 | Nuclear Ab pattern.course speckled [Titer] in Serum by Immunofluorescence | Nuclear Ab pattern.course speckled |
53986-6 | Nuclear Ab pattern.course speckled [Presence] in Serum by Immunofluorescence | Nuclear Ab pattern.course speckled |
53002-2 | Nuclear Ab pattern.fine speckled [Titer] in Serum by Immunofluorescence | Nuclear Ab pattern.fine speckled |
53984-1 | Nuclear Ab pattern.fine speckled [Presence] in Serum by Immunofluorescence | Nuclear Ab pattern.fine speckled |
20398-4 | Nuclear Ab Pattern Homogenous [Titer] in Serum | Nuclear Ab pattern.homogeneous |
53983-3 | Nuclear Ab Pattern Homogenous [Titer] in Serum by Immunofluorescence | Nuclear Ab pattern.homogeneous |
53999-9 | Nuclear Ab pattern.multiple nuclear dots [Presence] in Serum by Immunofluorescence | Nuclear Ab pattern.multiple nuclear dots |
54000-5 | Nuclear Ab pattern.multiple nuclear dots [Titer] in Serum by Immunofluorescence | Nuclear Ab pattern.multiple nuclear dots |
53997-3 | Nuclear Ab pattern.nuclear dots [Presence] in Serum by Immunofluorescence | Nuclear Ab pattern.nuclear dots |
53998-1 | Nuclear Ab pattern.nuclear dots [Titer] in Serum by Immunofluorescence | Nuclear Ab pattern.nuclear dots |
53995-7 | Nuclear Ab pattern.nuclear matrix [Titer] in Serum by Immunofluorescence | Nuclear Ab pattern.nuclear matrix |
53996-5 | Nuclear Ab pattern.nuclear matrix [Presence] in Serum by Immunofluorescence | Nuclear Ab pattern.nuclear matrix |
54005-4 | Nuclear Ab pattern.nuclear membrane pores [Presence] in Serum by Immunofluorescence | Nuclear Ab pattern.nuclear membrane pores |
54006-2 | Nuclear Ab pattern.nuclear membrane pores [Titer] in Serum by Immunofluorescence | Nuclear Ab pattern.nuclear membrane pores |
20399-2 | Nuclear Ab pattern.nucleolar [Titer] in Serum | Nuclear Ab pattern.nucleolar |
42212-1 | Nuclear Ab pattern.nucleolar [Titer] in Body fluid | Nuclear Ab pattern.nucleolar |
53991-6 | Nuclear Ab pattern.nucleolar [Titer] in Serum by Immunofluorescence | Nuclear Ab pattern.nucleolar |
53992-4 | Nuclear Ab pattern.nucleolar [Presence] in Serum by Immunofluorescence | Nuclear Ab pattern.nucleolar |
20400-8 | Nuclear Ab pattern.rim [Titer] in Serum | Nuclear Ab pattern.rim |
42213-9 | Nuclear Ab pattern.rim [Titer] in Body fluid | Nuclear Ab pattern.rim |
20401-6 | Nuclear Ab pattern.speckled [Titer] in Serum | Nuclear Ab pattern.speckled |
42214-7 | Nuclear Ab pattern.speckled [Titer] in Body fluid | Nuclear Ab pattern.speckled |
17380-7 | Nuclear Ab.histone reactive [Presence] in Serum | Nuclear Ab.histone reactive |
21424-7 | Nuclear IgG Ab [Presence] in Serum by Immunofluorescence | Nuclear Ab.IgG |
29950-3 | Nuclear IgG Ab [Presence] in Serum by Immunoassay | Nuclear Ab.IgG |
31545-7 | Nuclear IgG Ab [Presence] in Serum | Nuclear Ab.IgG |
42331-9 | Nuclear IgG Ab [Units/volume] in Serum by Flow cytometry (FC) | Nuclear Ab.IgG |
31134-0 | Nuclear matrix protein 22 [Units/volume] in Urine | Nuclear matrix protein 22 |
50666-7 | Nuclear matrix protein 22 [Presence] in Urine | Nuclear matrix protein 22 |
34737-7 | Nuclear mitotic apparatus Ab [interpretation] in Serum or Plasma | Nuclear mitotic apparatus Ab |
44645-0 | None | Nuclear pleomorphism |
54025-2 | Nuclear pore protein gp210 Ab [Presence] in Serum | Nuclear pore protein gp210 Ab |
50375-5 | Nucleated cells [#/volume] in Bronchial specimen by Manual count | Nucleated cells |
50774-9 | Nucleated cells [#/volume] in Blood | Nucleated cells |
51926-4 | Nucleated cells [#/volume] in Peritoneal fluid by Manual count | Nucleated cells |
52815-8 | Nucleated cells [#/volume] in Pericardial fluid by Automated count | Nucleated cells |
52816-6 | Nucleated cells [#/volume] in Cerebral spinal fluid by Automated count | Nucleated cells |
52817-4 | Nucleated cells [#/volume] in Dialysis fluid by Automated count | Nucleated cells |
52818-2 | Nucleated cells [#/volume] in Peritoneal fluid by Automated count | Nucleated cells |
52819-0 | Nucleated cells [#/volume] in Pleural fluid by Automated count | Nucleated cells |
53557-5 | Nucleated cells [#/volume] in Synovial fluid by Manual count | Nucleated cells |
34416-8 | Nucleosome Ab [Units/volume] in Serum by Immunoassay | Nucleosome Ab |
53014-7 | Nucleosome Ab [Units/volume] in Serum | Nucleosome Ab |
53015-4 | Nucleosome Ab [Presence] in Serum | Nucleosome Ab |
9800-4 | Number of Stones | Number |
45835-6 | None | Number days injections received |
45886-9 | None | Number days recreation therapy administered for greater than 15 min |
45875-2 | None | Number hospital admissions in last 90 days |
30974-0 | None | Number of brothers and sisters |
45837-2 | None | Number of days antianxiety medication received |
45838-0 | None | Number of days antidepressant medication received |
45836-4 | None | Number of days antipsychotic medication received |
45840-6 | None | Number of days diuretic medication received |
30950-0 | None | Number of days hospitalized due to vaccination adverse event |
45839-8 | None | Number of days hypnotic medication received |
45860-4 | None | Number of days of active range of motion |
45869-5 | None | Number of days of other rehabilitation or restorative techniques or procedures |
45859-6 | None | Number of days of passive range of motion |
45861-2 | None | Number of days of splint or brace assistance |
45867-9 | None | Number of days of training & skill practice in amputation or prosthesis care |
45862-0 | None | Number of days of training & skill practice in bed mobility |
45868-7 | None | Number of days of training & skill practice in communication |
45865-3 | None | Number of days of training & skill practice in dressing or grooming |
45866-1 | None | Number of days of training & skill practice in eating or swallowing |
45863-8 | None | Number of days of training & skill practice in transfer |
45864-6 | None | Number of days of training & skill practice in walking |
45878-6 | None | Number of days physician orders changed in last 14 days |
45762-2 | None | Number of days with at least 15 minutes of occupational therapy in the last 7 days |
45764-8 | None | Number of days with at least 15 minutes of physical therapy in the last 7 days |
45768-9 | None | Number of days with at least 15 minutes of psychological therapy in the last 7 days |
45766-3 | None | Number of days with at least 15 minutes of respiratory therapy in the last 7 days |
45760-6 | None | Number of days with at least 15 minutes of speech language pathology and audiology services in the last 7 days |
45876-0 | None | Number of emergency room visits in last 90 days |
10581-7 | Number of entities [#] in Spermatazoa | Number of entities |
33747-7 | None | Number of fragmented pieces |
45248-2 | None | Number of hospital days since last outpatient visit |
34049-7 | None | Number of impressions |
52478-5 | None | Number of Major Wounds |
45833-1 | None | Number of medications |
52007-2 | Ambulance transport, number of patients | Number of patients |
45877-8 | None | Number of physician visits in last 14 days |
46536-9 | None | Number of pressure ulcers - stage 1 |
46537-7 | None | Number of pressure ulcers - stage 2 |
46538-5 | None | Number of pressure ulcers - stage 3 |
46539-3 | None | Number of pressure ulcers - stage 4 |
52575-8 | None | Number of pressure ulcers at assessment - stage 2 |
52576-6 | None | Number of pressure ulcers at assessment - stage 3 |
52577-4 | None | Number of pressure ulcers at assessment - stage 4 |
52578-2 | None | Number of pressure ulcers at assessment - unstageable |
46460-2 | None | Number of pressure ulcers at each stage |
52579-0 | None | Number of pressure ulcers onset during this service - stage 2 |
52580-8 | None | Number of pressure ulcers onset during this service - stage 3 |
52581-6 | None | Number of pressure ulcers onset during this service - stage 4 |
52582-4 | None | Number of pressure ulcers onset during this service - unstageable |
30960-9 | None | Number of previous doses |
21959-2 | None | Number of radiation Rx |
19800-2 | None | Number of specimens obtained |
42185-9 | Number of specimens obtained of Unspecified specimen | Number of specimens obtained |
38527-8 | Number of specimens received of Study Stool | Number of specimens received |
42186-7 | Number of specimens received of Unspecified specimen | Number of specimens received |
38526-0 | Number of specimens tested of Study Stool | Number of specimens tested |
42187-5 | Number of specimens tested of Unspecified specimen | Number of specimens tested |
46544-3 | None | Number of stasis ulcers |
41950-7 | None | Number of steps |
41951-5 | None | Number of steps |
41952-3 | None | Number of steps |
46548-4 | None | Number of surgical wounds |
44656-7 | None | Number of tissue chips |
42033-1 | None | Number of tumors & histologies |
42032-3 | None | Number of tumors at diagnosis |
52476-9 | None | Number of unhealed pressure ulcers at each stage |
52583-2 | None | Number of unhealed stage 2 ulcers known to be present for more than 1 month |
11543-6 | Nursery records | Nursery records |
34080-2 | None | Nursing mothers section |
46208-5 | Nursing notes | Nursing notes |
46066-7 | None | Nursing rehabilitation and restorative care |
52836-4 | None | Nursing unit cost center |
52835-6 | None | Nursing unit name |
6188-7 | Nutmeg IgE Ab [Units/volume] in Serum | Nutmeg Ab.IgE |
15874-1 | Nutmeg IgE Ab RAST class in Serum | Nutmeg Ab.IgE.RAST class |
7527-5 | Nutmeg IgG Ab [Units/volume] in Serum | Nutmeg Ab.IgG |
21425-4 | Nutmeg IgG Ab RAST class in Serum | Nutmeg Ab.IgG.RAST class |
28181-6 | None | Nutrition alteration |
38225-9 | None | Nutrition intake pattern |
45794-5 | None | Nutrition or hydration intervention to manage skin problems |
39200-1 | None | Nutrition screen assessment |
39203-5 | None | Nutrition screen finding recency |
39202-7 | None | Nutrition screen follow-up status |
39201-9 | None | Nutrition screen results indicator |
28314-3 | None | Nutrition.behavior |
28495-0 | None | Nutrition.behavior |
46846-2 | None | Nutrition.behavior |
28315-0 | None | Nutrition.knowledge |
28496-8 | None | Nutrition.knowledge |
46847-0 | None | Nutrition.knowledge |
28316-8 | None | Nutrition.status |
28497-6 | None | Nutrition.status |
46848-8 | None | Nutrition.status |
46042-8 | None | Nutritional approaches |
46148-3 | None | Nutritional approaches (quarterly RUG-III) |
46139-2 | None | Nutritional approaches (quarterly) |
45749-9 | None | Nutritional approaches - none of above |
46041-0 | None | Nutritional problems |
45740-8 | None | Nutritional problems - none of above |
50056-1 | Nutritional risk index | Nutritional risk index |
45909-9 | None | Nutritional status trigger |
29085-8 | None | Nystagmus examination |
29086-6 | None | Nystagmus examination |
29758-0 | None | Nystagmus examination |
29759-8 | None | Nystagmus examination |
10697-1 | Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC) | Nystatin |
10698-9 | Nystatin [Susceptibility] by Minimum lethal concentration (MLC) | Nystatin |
18958-9 | Nystatin [Susceptibility] | Nystatin |
35824-2 | Nystatin [Susceptibility] by Disk diffusion (KB) | Nystatin |